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ABSTRACT
DOWNHILL RUNNING IMPAIRS ACTIVATION AND STRENGTH OF THE ELBOW
FLEXORS

by

Kyle J. Brandenberger

Under the Direction of Dr. J. Andrew Doyle

PURPOSE: The aim of this study was to determine if knee extensor injury induced by 1
h of downhill running attenuated force production in uninjured skeletal muscle (e.g., elbow
flexors). METHODS: Recreationally active subjects (n = 12) completed a two group (injury vs
control) repeated measures design with the injury group running downhill for 1 h and the control
group performing only the measurement procedures. Strength and percent voluntary muscle
activation were measured using an isokinetic dynamometer and electrical stimulation of the
elbow flexors and knee extensors before and after a fatigue protocol at the following time points
in relation to the downhill run: 15 min pre, 15 min post, 24 h post, and 48 h post. Blood samples
were collected at the same time points to measure IL-1β and TNF-α concentrations. RESULTS:
Knee extensor strength was significantly reduced by 53.5±9.9% immediately post-injury and
remained reduced for up to 48 h in the injury group. Elbow flexor strength was significantly
reduced immediately and 24 h post-injury by 13.2±3.9% and 17.3±4.0% respectively in the
injury group. Elbow flexor electrically stimulated strength was not found to be different at any
time point (P = 0.561). Elbow flexor activation was significantly reduced compared to control at

24 and 48 h post-injury by 22.9±9.1% and 13.5±5.7% respectively. No differences were
observed in IL-1β or TNF-α between groups. CONCLUSION: A 1 h downhill run significantly
injured the knee extensors. The elbow flexor muscles remained uninjured based on electrically
stimulated strength, but voluntary strength of these muscles was impaired due to reduced
activation. This suggests an injury to the knee extensors can impair strength in uninjured
muscles by reducing voluntary activation. The mechanism behind this reduction remains
undetermined.

INDEX WORDS: Downhill running, Muscle injury, Central nervous system, Inflammation
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DEFINITIONS
Adenosine Triphosphate (ATP): A high energy molecule containing three phosphate groups
used in various cellular processes to provide energy.

Creatine Phosphate (PCr): A high energy molecule used by cells to produce energy
anaerobically.

Cyclooxygenase (COX): An enzyme responsible for synthesizing prostaglandin E2.

Graded Exercise Test (GXT): An aerobic fitness test where the subject’s expired gas is
measured for oxygen consumption. Subjects run on a treadmill and the speed is increased at
fixed intervals until the subject cannot maintain their speed.

Injury: A state of long-lasting impaired function resulting from physical damage to
organs/tissue/cells in a biological system.

Interleukin 1β (IL-1β): A pro-inflammatory cytokine which binds to the IL-1 receptor.

Interleukin 1receptor antagonist (IL-1ra): a competitive inhibitor of IL-1β which binds to the IL1 receptor and prevents signaling.

Maximal voluntary contraction (MVC): A muscle contraction in which the subject voluntarily
produces the maximum amount of force they can achieve.

x

Nuclear Factor Kappa B (NF-κB): A transcription factor that is sensitive to reactive oxygen
species.

Peak Oxygen Consumption (VO2peak): The highest oxygen consumption observed during a
maximal effort GXT.

Prostaglandin E2 (PGE2): A messenger particle synthesized by Cyclooxygenase.

Sarcoplasmic Reticulum (SR): An organelle within a muscle cell which stores and releases
calcium.

Tumor Necrosis Factor alpha (TNFα): A pro-inflammatory cytokine.

Twitch Interpolation (TI): A technique used to quantify the percentage of muscle activated in a
voluntary contraction.

Voluntary Muscle Activation (VMA): The percentage of muscle that can be activated by a
subject without direct outside stimulation of the nervous system compared with activation when
directly stimulating the target nerve.

xi

CHAPTER ONE

REVIEW OF LITERATURE
Introduction
Fatigue can be very broadly defined as a decline in force production not due to physical
injury of the working muscle. Numerous situations can result in fatigue, and the cause of
declining force production is often multifactorial. In order to more fully understand fatigue, it is
necessary to isolate the different causes to determine why force production declines in a given
scenario.

Peripheral Fatigue
Peripheral fatigue refers to a decrement in a given muscle fiber’s ability to maximally
produce force. Peripheral fatigue has been attributed to changes within the muscle that reduce
the muscle fiber’s ability to produce maximal force. The muscle fiber relies on the release of
calcium from the sarcoplasmic reticulum (SR) as a signal to initiate muscle contraction (S Ebashi
& Endo, 1968; Riiegg, 1988). Sufficient calcium must be present in the muscle cytosol to bind
to troponin C, which leads to a conformational shift, exposing the myosin binding site on actin
(Setsuro Ebashi, Endo, & Ohtsuki, 1969). Since calcium is crucial to the development of force
by a muscle fiber, anything that significantly decreases SR calcium release would lead to a
reduction in maximal force production of the individual fiber and thereby decreasing the overall
force production capability of the muscle (Riiegg, 1988).
1

Metabolic changes
During prolonged, intense muscle contractions, a number of metabolic changes occur in
the muscle. Accelerated use of ATP and depletion of the creatine phosphate (PCr) stores leads to
increased levels of free creatine and inorganic phosphate (Pi). While free creatine has not been
linked to any change in force production the associated rise in Pi has been shown to have a direct
effect on the calcium stores in the SR by causing calcium to precipitate (D. Allen & Westerblad,
2001; Westerblad, Allen, & Lännergren, 2002). The reduced SR calcium leads to a reduced
calcium transient, which in turn leads to reduced force production as fewer cross bridges are
formed (D. Allen & Westerblad, 2001; D. G. Allen, Kabbara, & Westerblad, 2002). Early
studies on skinned fibers suggested a significant role for acidosis on reductions in force
production (Cooke, Franks, Luciani, & Pate, 1988; Donaldson, Hermansen, & Bolles, 1978;
Metzger & Moss, 1987). However, it was subsequently determined that the effects of pH on
muscle force production become less significant at physiological temperatures (Pate, Bhimani,
Franks-Skiba, & Cooke, 1995). More recent research has even suggested that reductions in pH
can preserve force production (O. B. Nielsen, Paoli, & Overgaard, 2001).

Glycogen Depletion
Glycogen depletion has been associated with fatigue in numerous studies (Jacobs, Kaiser,
& Tesch, 1981; Tsintzas, Williams, Boobis, & Greenhaff, 1996; Wagenmakers et al., 1991). It
was originally thought that depletion of muscle glycogen caused fatigue consequent to reduced
ATP resynthesis, but the evidence suggests that ATP concentrations are maintained even when
glycogen is depleted (J. Nielsen, Schrøder, Rix, & Ørtenblad, 2009; Stephenson, Nguyen, &
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Stephenson, 1999). Some evidence now suggests that depletion of glycogen reduces calcium
release from the ryanodine receptor through an unknown signaling mechanism (Chin & Allen,
1997; Ørtenblad, Nielsen, Saltin, & Holmberg, 2011).

Oxidative Stress
Some evidence exists that acute exercise is capable of increasing oxidative stress
(Bloomer, Goldfarb, Wideman, McKenzie, & Consitt, 2005; M. B. Reid, Shoji, Moody, &
Entman, 1992), and that training blunts this increase in oxidative stress by upregulating gene
expression via Nuclear Factor Kappa B (NF-κB) signaling (Gomez-Cabrera, Domenech, &
Viña, 2008; Miyazaki et al., 2001). The specific role of oxidative stress in fatigue is
incompletely understood. It appears that some basal level of oxidative stress is needed for
adequate force generation (Michael B Reid, Khawli, & Moody, 1993), but increasing oxidative
stress beyond a certain level impairs force development via reducing calcium release and
possibly altering calcium sensitivity of the contractile proteins (Michael B Reid, 2008).

Central Fatigue
The role of the central nervous system in fatigue has been recognized for over a hundred
years since it was first demonstrated that mentally challenging work could affect physical
performance (Mosso, 1904). Central fatigue can be defined as a transient reduction in the ability
of the central nervous system (CNS) to voluntarily fully recruit motor units (Gandevia, 2001).
Voluntary recruitment of motor units occurs when the motor cortex generates an action potential
that travels down the spinal cord through alpha motor neurons to activate a muscle. The spinal
cord then integrates the level of stimulation from the brain with peripheral signals from muscle
3

afferents to select the appropriate level of motor unit recruitment (J. B. Nielsen, 2004). Evidence
suggests that CNS dysfunction can occur at the supraspinal level due to suboptimal output from
the motor cortex (Gandevia, Allen, Butler, & Taylor, 1996; Taylor, Allen, Butler, & Gandevia,
2000; Taylor, Todd, & Gandevia, 2006), or at the spinal level due primarily to altered afferent
feedback from the group III and IV afferents (Amann & Dempsey, 2008; Amann et al., 2008;
Amann, Proctor, Sebranek, Pegelow, & Dempsey, 2009) (see Figure 1.1).

Figure 1.1. Central versus peripheral fatigue. Depicting the different sites in the neuromuscular
system necessary for force development. Fatigue can occur due to dysfunction in any one of
these sites leading to reduced force production (Taylor, Amann, Duchateau, Meeusen, & Rice,
2016)

4

Supraspinal Fatigue
The precise mechanisms that lead to development of central fatigue are not entirely
understood at present. The first proposed mechanism for central fatigue suggested that
alterations in brain serotonin were responsible for reductions in force generating capability
(Romanowski & Grabiec, 1973). This was later expanded upon to suggest a role for free fatty
acids displacing tryptophan from albumin and increasing brain uptake of free tryptophan which
is converted into serotonin within the brain (Acworth, Nicholass, Morgan, & Newsholme, 1986;
Chaouloff, Kennett, Serrurrier, Merino, & Curzon, 1986; Curzon, Friedel, Katamaneni,
Greenwood, & Lader, 1974; Newsholme, 1987; Pardridge, 1979). However, studies on
serotonin’s role in central fatigue have had conflicting results, suggesting that other mechanisms
may play a role (Roelands & Meeusen, 2010).

There is some evidence to suggest that dopamine, another neurotransmitter plays a
significant role in the initiation of force production. A meta-analysis of examining dopamine
reuptake inhibitors to treat cancer related fatigue in 2010 found a significant (effect size = 0.28)
improvement in fatigue when measured using a subjective rating scale (Minton, Richardson,
Sharpe, Hotopf, & Stone, 2011). However, previous researchers have suggested that dopamine
alterations are a downstream consequence of the inflammation occurring in the brain, with the
proposed pathway below (see Figure 1.2) (Bower & Lamkin, 2013). Supporting this conclusion,
treatment with dopamine elevating medications have mixed results on reducing fatigue in
Parkinson’s patients (J. S. Lou et al., 2003; Mendonça, Menezes, & Jog, 2007; Valko et al.,
2010).

5

Figure 1.2. Inflammation alters dopamine levels resulting in fatigue. Inflammation from systemic
causes related to cancer can impair dopamine signaling leading to fatigue (Bower & Lamkin,
2013).

Modulating Force
The motor unit is comprised of the alpha motor neuron and the muscle fibers it innervates. A
motor unit is the lowest functional unit of the neuromuscular system capable of producing force (Taylor et
al., 2016). The central nervous system is capable of modulating force production via two

approaches, both involving the activation of the motor unit (J. H. Friedman et al., 2007;
Heckman & Enoka, 2012). The first approach is to change the number of motor units recruited.
6

Motor units are normally recruited based on size, with the smallest motor units recruited first (J.
H. Friedman et al., 2007; Heckman & Enoka, 2012). Once a given motor unit is recruited, the
force can be altered by changing the rate at which action potentials are delivered to the motor
unit (Taylor et al., 2016). During a brief contraction, the rate of action potentials can vary
considerably, but functionally muscles tend to peak between 10-40 Hz of activation (Fuglevand,
Lester, & Johns, 2015; Mottram, Heckman, Powers, Rymer, & Suresh, 2014; Taylor et al.,
2016). During fatiguing tasks involving MVCs, motor unit firing rates have been consistently
shown to decline (Bigland-Ritchie, Dawson, Johansson, & Lippold, 1986; Dalton, Harwood,
Davidson, & Rice, 2010; Taylor et al., 2016; Woods, Furbush, & Bigland-Ritchie, 1987). This
reduction in motor unit firing rate is likely attributed to reductions in neural drive, local changes
in the motoneurons, of inhibitory feedback mechanisms (Heckman & Enoka, 2012; Taylor et al.,
2016). During submaximal fatiguing contractions firing rates are extremely variable with
intensity, type of task performed, muscle location, muscle architecture, and training status
influencing changes (Taylor et al., 2016). Following a bout of eccentric exercise, it appears that
rate coding increases, as the CNS attempts to compensate for losses in force (De Ruiter, Elzinga,
Verdijk, Van Mechelen, & De Haan, 2005; Piitulainen, Holobar, & Avela, 2012).

Motor Neuron Excitability

The alpha motor neurons play an integral role in the development of force, because they
are the last link in the nervous system necessary for activation of a particular motor unit. The
alpha motor neuron and the muscle fibers that make up the motor unit form a one to many
relationship making the (Taylor & Gandevia, 2008) firing of the motor unit reflect the firing
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alpha motor neuron in a one-one ratio (Taylor et al., 2016). The excitability of the motor neuron
is influenced by corticospinal drive, neurotransmitters, afferent nerve input and the current level
of activation of the given motor neuron (Taylor et al., 2016) (see Figure 1.3) . Evidence suggests
that during fatiguing contractions the motor neurons are less responsive to excitation, which
would reduce their firing rate leading to the recruitment of additional motor units (Carpentier,
Duchateau, & Hainaut, 2001; Johnson, Edwards, Van Tongeren, & Bawa, 2004; Taylor et al.,
2016).

Figure 1.3. Motor unit recruitment varies with intensity. A summary of the differences in motor
unit recruitment for maximal versus submaximal contractions (Taylor & Gandevia, 2008).
The role of serotonin in fatigue was previously discussed in the context of the central
nervous system. However, researchers have suggested that serotonin plays a complex role in the
excitability of the motor neurons (Taylor et al., 2016). Evidence suggests that low levels of
serotonin increase motor neuron excitability when confined to the somatodendritic membrane,
but when levels of serotonin are high enough to spill over onto the axonal initial segment, motor
neuron excitability is decreased (Cotel, Exley, Cragg, & Perrier, 2013). This likely occurs via
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the distribution of 5-HT2 excitatory and 5-HT1A inhibitory serotonin receptors (Cotel et al.,
2013). Studies suggest that serotonin is released in a graded response to force (Wei et al., 2014) ,
but at least during rhythmic activities of running with a sufficient time frame the level of
serotonin release will decline, taking 30-45 minutes to recover (Fornal, Martín-Cora, & Jacobs,
2006; Gerin, Becquet, & Privat, 1995).

Motor neuron excitability can also be altered via afferent feedback (Enoka et al., 2011;
Taylor et al., 2016). The motor neuron receives input from excitatory sources (descending drive,
and muscle spindle afferents) and inhibitory sources (Golgi tendon afferents, Renshaw cells, and
group III/IV afferents) (Taylor et al., 2016). Of the inhibitory sources, only the group III/IV
afferents are thought to play a significant role in force loss during fatigue. (Amann & Dempsey,
2008; Gandevia, 2001; Hilty et al., 2011; P. G. Martin, Smith, Butler, Gandevia, & Taylor, 2006;
Pettorossi, Torre, Bortolami, & Brunetti, 1999; Woods et al., 1987). The muscle spindle
afferents promote motor neuron excitation. During a sustained contraction, there is a decline in
muscle spindle activity, leading to reduced motor unit excitation (Macefield, Hagbarth, Gorman,
Gandevia, & Burke, 1991). From studies of the short latency H-reflex, comprising a spinal loop,
there is evidence to suggest that muscle spindle firing primarily leads to changes at the spinal
level that in turn lead to presynaptic inhibition of the motor neuron pool (Duchateau, Balestra,
Carpentier, & Hainaut, 2002; Duchateau & Hainaut, 1993). In contrast there is a differential
response on the long latency reflex, with no change during maximal efforts, but a decline at
submaximal efforts (Duchateau et al., 2002) (see Figure 1.4).
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Figure 1.4. Motor Neuron excitability. Depicting the different factors affecting motor neuron
excitability (Taylor et al., 2016).
Group III and IV Afferents
Sensory nerves that innervate skeletal muscle can be activated by contractions. These sensory
nerves are classified based on function, and physical properties into group I, II, III or IV. The
group III and IV afferent nerves are thought to play an important role during fatiguing
contractions. The group III afferents are largely responsive to mechanical stimulation from
muscle contraction, and the group IV afferents are sensitive to metabolites (Taylor et al., 2016).
These group III/IV afferents play a significant role in relaying information to the central nervous
system for the regulation of cardiopulmonary response to exercise. Evidence suggests that these
afferents influence the rapid increase in cardiopulmonary output during exercise (Amann et al.,
2010; Kaufman & Forster, 1996). Since O2 delivery to the working muscles limits development
of fatigue in the working muscles (Amann & Calbet, 2008), the faciliatory effects of group
III/IV afferents on the cardiopulmonary system could be thought to reduce peripheral fatigue
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(Taylor et al., 2016). Additional studies suggest that fatiguing byproducts, such as hydrogen and
Pi, can activate group III and IV which alter spinal function and reduces motor unit recruitment
to possibly avoid the development of severe peripheral fatigue (Amann & Dempsey, 2008;
Amann et al., 2008; Amann et al., 2009). It is thought that group IV afferents can alter central
motor drive since the information from group IV afferents is communicated to the brain (Amann,
2011; Gandevia, 2001). This inhibition can also affect recruitment of distant limbs (Sidhu et al.,
2014). A 2004 study suggests that intramuscular inflammation due to skeletal muscle injury can
sensitize group IV afferents leading to reduced voluntary muscle activation within the same
muscle (Marqueste et al., 2004) (see Figure 1.5).

Figure 1.5. Muscle afferents interactions. Depicting the complex role of group III and IV
afferents in the development of central and peripheral fatigue (Taylor et al., 2016).
Central vs Peripheral Fatigue
As the previous sections illustrate, fatigue likely occurs through a combination of overlapping
mechanisms that include both peripheral factors intrinsic to the individual muscle fibers, and
central factors involving the brain, spinal cord and alpha motor neurons. While the cellular
environment of a muscle cell can be altered through exhaustive exercise and lead to a loss of the
intrinsic force production of the muscle (Fitts, 1994), The central nervous system also clearly
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plays a role in determining the level of motor unit recruitment. Peripheral mechanisms also do
not explain the loss of force observed in submaximal exercise below thresholds thought to
produce excessive fatiguing byproducts, which is distinguished by a decrease in voluntary
muscle activation (V. Martin et al., 2010). The interplay between peripheral mechanisms of
fatigue and central factors is complex, and the extent to which each mechanism contributes to the
overall development of fatigue depends on the task and conditions of the performance (Taylor et
al., 2016).

Measuring Fatigue
Previous researchers have suggested that measuring fatigue is difficult because the very
concept of fatigue is difficult to define (Eidelman, 1979; Muscio, 1921). Despite this difficulty,
there are a number of methods used to measure fatigue. One of the earliest methods developed
to study fatigue involved a subjective rating scale based on subject observation and feedback
(Krupp, LaRocca, Muir-Nash, & Steinberg, 1989; Pearson, 1957; Pearson & Byars Jr, 1956;
Yoshitake, 1971). While useful, these rating scales are subjective and lack the precision needed
to determine either the cause or magnitude of any fatigue present. In spite of the drawbacks,
fatigue rating scales are still employed in numerous studies (Barsevick et al., 2004; Given, 2002;
Jean‐Pierre et al., 2010; Lower et al., 2009) to assess fatigue. Despite the apparent subjectivity
of fatigue, there are more objective measures commonly used to quantify the magnitude of
fatigue present in subjects.

Numerous studies have examined fatigue using tests to fatigue, where a subject performs
an exercise at a constant work rate until they can no longer maintain the desired work rate (E.
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Coyle et al., 1983). The benefit to this type of measurement is that it mimics competitive
activities and is easily translatable to performance. It has been used extensively to examine
metabolism and fuel utilization (Coggan & Coyle, 1987; E. Coyle et al., 1983; E. F. Coyle,
Coggan, Hemmert, & Ivy, 1986). This method has also been used to study the effects of
inflammation on fatigue in animal models (Carmichael et al., 2006). Unfortunately, the
drawback to this method is its inability to determine whether the fatigue occurs in the peripheral
muscle or the central nervous system.

Another method of measuring fatigue is to measure maximal voluntary contraction
(MVC). Measuring force production during a MVC has advantages when studying central
fatigue because, force generated during an MVC involves the entire pathway from the brain to
the skeletal muscle (Taylor & Gandevia, 2008). The drawback to this procedure is that the
results of any changes in MVC strength may not directly translate into functional/performance
applications since movements in daily activity or sport rarely involve MVC type of muscle
action. However, and MVC remains the best way to test both the peripheral muscle and the
central nervous system. Therefore, an MVC can be used to assess the function of the entire
nervous system from brain to the alpha motor neurons.

Measuring Activation
The relationship between muscle activation and electrical current has been known for
several centuries (Galvani & Aldini, 1792). The first recorded EMG were reported in 1849 (Du
Bois-Reymond, 1849), and subsequently, the technique has been refined through the use of
various technology to record an analyze the small electrical signals due to the movement of ions
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involved in muscle contraction (Fridlund & Cacioppo, 1986; Kamen & Caldwell, 1996).
Measurements of activation relying on EMG signals suffer from two major drawbacks. First, the
voltages recorded are very small in the μV range, making them highly susceptible to interference
from outside sources which would need to controlled (Fridlund & Cacioppo, 1986). Second,
there is no way to ascertain based on the voltage of the muscle whether the there is any portion
that remains inactive. Third, the reliability of EMG measurements decreases with increasing
intensities of exercise, making them unreliable for measurements during a maximal voluntary
contraction (Dankaerts, O’Sullivan, Burnett, Straker, & Danneels, 2004; Mathur, Eng, &
MacIntyre, 2005; Yang & Winter, 1983).

Twitch interpolation is a technique used to quantify the amount of muscle voluntarily
activated during a contraction (Shield & Zhou, 2004). During a maximal contraction, a stimulus
is applied to the either the nerve innervating the muscle, or directly to the muscle belly with
surface electrodes. The additive force of the twitch is then compared to a twitch induced during
relaxation from the MVC, known as a control twitch. The following equation is then used to
estimate the percentage of voluntary muscle activation during the maximal contraction (Shield &
Zhou, 2004).

Voluntary Activation percentage = (1 – Superimposed Twitch Torque / Control Twitch Torque)
X 100 (G. Allen, Gandevia, & McKenzie, 1995).

The control twitch torque in conjunction with the superimposed twitch torque can be used to
quantify the level of dysfunction/fatigue within the muscle (Park et al., 2008). The
superimposed twitch torque represents the amount of muscle not activated during the voluntary
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contraction (Shield & Zhou, 2004). Combining these measures can be used to determine how
much of the fatigue is due to central activation or changes within the muscle.

This technique can be applied to muscle injury to determine the relative contribution of
central and peripheral mechanisms to the force loss associated with injury. Changes in the
control twitch torque would represent changes intrinsic to the muscle fiber. Whereas, changes in
the superimposed twitch torque relative to the control twitch torque would represent changes in
central activation. If the injury is broadly affecting motor unit recruitment, then the ratio of
superimposed twitch torque to control twitch torque will be increased in uninvolved limbs.
Questions remain of whether the muscle injury is communicated into the brain producing
widespread changes, and what is the most likely mechanism for this communication?

Inflammation and Signaling
Inflammation is most commonly diagnosed and defined by the symptoms: redness,
swelling, heat, and pain (A. Scott, Khan, Cook, & Duronio, 2004). It has been shown that these
symptoms are the result of chemical messengers that broadly activate immune processes
throughout the body (Rocha e Silva, 1978). There are a variety of different chemical messengers
employed in this process that have both redundant and differential effects (Watkins, Maier, &
Goehler, 1995). Tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) are secreted
early in the inflammatory process and are referred to as “pro-inflammatory” cytokines because of
their role in upregulating inflammatory mediators such as nitric oxide and matrix
metalloproteinases (Pedersen et al., 2001). Interleukin 6 is also secreted early in the
inflammatory response, but appears to have both pro-inflammatory and anti-inflammatory effects
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(Barton, 1997).

Another set of cytokines including interleukin 1 receptor antagonist (IL-1ra),

soluble TNF-α receptors, TGFβ, interleukin 4, interleukin 10, and interleukin 13 have antiinflammatory effects (Cannon & Pierre, 1998; Pedersen et al., 2001).

Inflammation Communication across the Blood Brain Barrier
Originally it was thought that the brain was relatively immune privileged (Pachter, de
Vries, & Fabry, 2003), meaning that the blood brain barrier protected the brain from
experiencing the effects of inflammation. However, recent research in mice and humans has
provided good evidence that peripheral inflammation induced in mice via downhill running
(Carmichael et al., 2010), in human fetuses via lipopolysaccharide (Lee, Liu, Dickson, Brosnan,
& Berman, 1993), and various models of human disease (Gabay, Lamacchia, & Palmer, 2010),
can communicate across the blood brain barrier to induce inflammation in the brain itself. This
process is thought to be activated by inflammatory signaling of the molecule IL-1β which can
bind to the IL-1 receptor activating brain microglial cells, which then secrete prostaglandin E2
(PGE2) (Carmichael et al., 2010; Gabay et al., 2010; Harrington, 2012; Lee et al., 1993). It is
also thought that prolonged signaling through the IL-1 receptor can result in dysfunction of the
blood brain barrier itself and lead to infiltration of immune cells and inflammatory signaling
molecules directly into the brain. Evidence for this comes from an in-vitro model of endothelial
cells (Labus, Häckel, Lucka, & Danker, 2014).

Cerebral Inflammation and Sickness Behavior
Cerebral inflammation has been shown in mice to induce a variety of behavior changes
(fatigue, loss of appetite, reduced work capacity, etc...) often referred to collectively as sickness
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behavior. These behavior changes tend to peak 2-6 h following an inflammatory stimulus in
mice (Dantzer, O'Connor, Freund, Johnson, & Kelley, 2008), which matches the time frame
observed in studies of IL-1β signaling inhibition in humans showing a reduction in feelings of
fatigue after inhibiting IL-1 signaling (Fitzgerald, LeClercq, Yan, Homik, & Dinarello, 2005;
Verbsky & White, 2004).

Role of IL-1β in Fatigue
Studies have shown that IL-1 signaling impairs voluntary activity and time to fatigue in
mice following a bout of downhill running (Carmichael et al., 2005; Carmichael et al., 2006).
This concept is also supported by studies of voluntary activity after injection with an immune
stimulating substance in the absence of any injury, which have shown that reductions in
voluntary activity are strongly correlated with Il-1β levels in the brain (W. Sheng, Hu, Ding,
Chao, & Peterson, 2001; W. S. Sheng, Hu, Lamkin, Peterson, & Chao, 1996). Taken together,
these studies indicate that brain inflammation is communicated from the periphery in both injury
and sickness, and this brain inflammation causes a form of fatigue in mice. This phenomenon
has been linked specifically to brain macrophage like cells, which appear to be key in the
reduction of time to fatigue in treadmill running following eccentric exercise induced muscle
injury in mice (Carmichael et al., 2010). This phenomenon has then been applied to human
clinical fatigue, feelings of fatigue associated with sickness and disease that is associated with
inflammation, but without clear, direct evidence that this pathway is conserved in humans.

The evidence for IL-1β’s role in fatigue in humans largely comes from clinical studies of
conditions that involve elevated systemic inflammation. Numerous studies have shown that
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conditions associated with inflammation including: Multiple sclerosis (Leocani et al., 2001; Ng,
Miller, Gelinas, & Kent‐Braun, 2004; Sheean, Murray, Rothwell, Miller, & Thompson, 1997),
rheumatoid arthritis (Bearne, Scott, & Hurley, 2002; O’Reilly, Jones, Muir, & Doherty, 1998),
fibromyalgia (Nørregaard, Bülow, Vestergaard-Poulsen, Thomsen, & Danneskiold-Samsøe,
1995), and chronic fatigue (Schillings et al., 2004; Siemionow, Fang, Calabrese, Sahgal, & Yue,
2004), have a diminished capacity to voluntarily recruit motor units. While these studies do not
clearly show a causative effect of inflammation on reduced voluntary motor unit recruitment,
they do suggest that such an effect may occur, which other reviewers have suggested (Zwarts,
Bleijenberg, & Van Engelen, 2008). The work of T.D. Noakes suggests that the brain can
integrate numerous signals including, inflammation, temperature, blood glucose and
psychological factors to alter motor cortex function and ultimately affect motor unit recruitment
(Noakes, 2011). If inflammation can induce these behavior changes in humans, it will likely
affect motor unit recruitment, and maximal force production.

Force Loss after Muscle Injury
Skeletal muscle injury often occurs following novel eccentric muscle actions. This injury
can lead to functional deficits in the muscle which are disproportionate to the extent of physical
damage within the muscle fiber (Warren, Ingalls, Lowe, & Armstrong, 2002). It is generally
accepted that muscle injury leads to a loss of force production due to physical disruptions within
the cell of the force generating structures, and the structures involved in transmitting signals
from the nerve into the interior of the cell, also known as excitation contraction (E-C) uncoupling
(Warren et al., 2002). E-C uncoupling accounts for most of the early force loss (0-3 days) after
injury, whereas a frank loss of contractile proteins becomes more prominent 3-28 days after
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injury (Warren et al., 2002). There is evidence that skeletal muscle injury results not only in a
reduced intrinsic force producing capability, but also in what is classically thought to be central
fatigue. While Marqueste et al., 2004 dealt with the effects of intramuscular inflammation, the
literature suggests that prolonged eccentric exercise results in elevated plasma levels of IL-1β,
IL-6 and TNF-α (Moldoveanu, Shephard, & Shek, 2001; Peake, Nosaka, & Suzuki, 2005) which
might further impair muscle force production at the central level. A few studies have already
suggested that muscular function is partly related to IL-1β at the peripheral level (Marqueste et
al., 2004) and the central level (Carmichael et al., 2005; Carmichael et al., 2006) following
muscle injury.

Fatigability after Muscle Injury
There is also evidence that exercise induced muscle injury increases the fatigability of the
injured muscle (Asp, Daugaard, Kristiansen, Kiens, & Richter, 1998; Doncaster & Twist, 2012).
Although this increased fatigability has been thought to be attributed primarily to alterations in
the metabolic properties of the muscle after injury (Asp et al., 1998), this would not explain the
progressive decline in EMG signal observed in other studies during fatiguing contractions
(Hedayatpour, Falla, Arendt-Nielsen, & Farina, 2008). Interestingly, this same phenomenon has
been documented in patients with multiple sclerosis (Sheean et al., 1997). One of the factors
contributing to fatigue in multiple sclerosis is increased systemic inflammation (Gold & Irwin,
2009; Heesen et al., 2006; Trapp & Nave, 2008). Studies also suggest that inflammation induced
by the exercise protocols may affect the basal ganglia, which contain the brain’s reward centers
(Calabrese et al., 2010; Tellez et al., 2008).
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Inflammation Alters the Brain Reward Centers
One possible explanation for increased fatigability is that inflammation may alter the
function of the Substantia Nigra, known as the reward center, of the brain and thereby alters the
incentive to endure the pain associated with fatigue. This alteration has been observed in
humans during MRI scans of people after receiving a typhoid fever vaccine, a method of
inducing inflammation (Brydon, Harrison, Walker, Steptoe, & Critchley, 2008). Interestingly,
the subjects in that study also displayed psychomotor slowing, a possible sign of fatigue. This
interaction with the brain reward center has been shown in numerous other studies (Croisier,
Moran, Dexter, Pearce, & Graeber, 2005; Herrera, Tomas-Camardiel, Venero, Cano, &
Machado, 2005), and this region has also been linked to motor dysfunction as a result of
enhanced IL-1β signaling (Ferrari et al., 2006). Reviewers have even suggested that IL-1β
signaling is key to the pathophysiology of Parkinson’s Disease (Godoy, Tarelli, Ferrari, Sarchi,
& Pitossi, 2008; Nagatsu, Mogi, Ichinose, & Togari, 2000). Parkinson’s is also associated with
abnormal central fatigue, defined as the inability to initiate physical tasks (J. Friedman &
Friedman, 1993; J. H. Friedman et al., 2007; Karlsen, Larsen, Tandberg, & Jørgensen, 1999; J. S.
Lou, Kearns, Oken, Sexton, & Nutt, 2001). Alterations in the Substantia Nigra have been shown
to reduce integrated force during a 30 second fatiguing contraction via a loss of motor unit
recruitment (J.-S. Lou, 2005). Reducing the brain’s perceived reward from performing a painful
sustained contraction leads to a progressive loss in motor unit recruitment,
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Exercise Induced Muscle Injury Leads to Elevated IL-1β
While some researchers suggest that most of the IL-1β generated due to eccentric muscle
injury is retained within the injured muscle (J. Peake et al., 2005), the levels of IL-1β in plasma
are necessarily much smaller than those of other inflammatory cytokines because it becomes
cytotoxic above picomolar concentrations (Moldoveanu et al., 2001). This means the circulating
levels of IL-1β remain close to the detection threshold (Moldoveanu et al., 2001). Due to this,
results in the literature concerning IL-1β plasma concentrations following exercise have been
inconsistent (Moldoveanu et al., 2001; Suzuki et al., 2002). That some studies have shown
elevated plasma IL-1β levels following marathon running (Ostrowski, Rohde, Zacho, Asp, &
Pedersen, 1998), 5k runners (Netea et al., 1996) cycling (Haahr et al., 1991; Lewicki,
Tchorzewski, Majewska, Nowak, & Baj, 1988), and eccentric cycling (Evans et al., 1986)
suggests there may be small significant elevations in IL-1β following higher intensity (>75%
VO2max) exercise. As pointed out previously in the literature (Nieman et al., 1998), while IL1β is difficult to measure in plasma, its elevation in both muscle (Cannon et al., 1989; Fielding et
al., 1993) and urine (Sprenger et al., 1992) post injury suggests elevated levels are present in the
blood.
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Endurance Exercise Leads to Elevations in Pro-Inflammatory Cytokines

Most studies have shown that prolonged endurance exercise (≥60 min) results in elevated
plasma TNFα (Brenner et al., 1999; Dufaux & Order, 1989; Espersen et al., 1990; Moldoveanu,
Shephard, & Shek, 2000; Ostrowski, Rohde, Asp, & Pedersen, 1998; Rokitzki, Logemann, &
Keul, 1994; Sprenger et al., 1992) Shorter protocols tend to not illicit elevated plasma TNFα
levels (Brenner et al., 1999; Der Meer, 1998; Natelson et al., 1996), but one study using a 5 km
run was able to detect levels of TNFα after administration of lipopolysaccharide (Netea et al.,
1996). Studies of the effects of endurance exercise on circulating IL-6 are more consistent, with
studies showing consistent elevations in IL-6 of exercise ≥ 30 min (Brenner et al., 1999;
Moldoveanu et al., 2000; Ostrowski, Rohde, Asp, et al., 1998; Ostrowski, Rohde, Zacho, et al.,
1998; Ullum et al., 1994), with eccentric exercise resulting in significantly more IL-6
(Bruunsgaard et al., 1997; Nieman et al., 1998). Increases in IL-6 (25 to 100 fold increases) tend
to be larger than increases in either TNFα or IL-1β (~2.5 fold increase) (Ostrowski, Rohde, Asp,
et al., 1998) making it a more easily detectable marker of overall inflammation.

Detecting systemic IL-1β in Plasma and Urine
In order to circumvent the detection problem, it may be beneficial to test for IL-1β in the
urine because the concentrations would be higher and thus easier to detect. Studies of plasma
IL-1β have found basal levels < 10 pg/mL and post injuries levels typically below 100 pg/mL
(Ostrowski, Rohde, Zacho, et al., 1998; L. L. Smith et al., 2007), while studies of urine yield
results in the 100 – 300 pg/mL (Sprenger et al., 1992). In urine there is a delay in the time that
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significant levels are detected. The literature seems to indicate that a delay of 3 h following the
onset of exercise is needed before significant levels of IL-1β appear in the urine (se Figure 6.6).

Fig 1.6. Concentration of IL-1β detected in urine from the start of a 2 h run. Levels of IL-1β
were assessed in urine before, immediately after (2h) and at the other time points indicated
(Sprenger et al., 1992).
Exercise Intensity, and Training Status Influences IL-1β levels
Evidence suggests that higher intensity exercise produces significantly more
inflammation than moderate or low intensity exercise of the same duration (J. M. Peake, K.
Suzuki, M. Hordern, et al., 2005). In support of this, studies employing a race format with
subjects attempting to achieve the fastest time possible tend to produce significant levels of IL-6
(Ostrowski, Rohde, Zacho, et al., 1998; Sprenger et al., 1992). Evans et al., 1986 found that
untrained men had significantly more inflammation than trained men; however, the workload
between groups was a fixed 200 W, making it difficult to determine whether changes in relative
work rate were responsible for the reduced inflammation in the trained group (Evans et al.,
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1986). It is likely that the results of Evans et al., 1986 reflect the importance of relative intensity
on the inflammatory response. Most studies showing significant elevations in IL-1β used
relative work intensities between 75-80% of VO2max (Cannon et al., 1989; Pournot et al., 2011;
J. P. Scott et al., 2013). Therefore, any study attempting to induce a uniform inflammatory
response should scale the intensity to a percentage of maximal effort instead of a fixed work rate.

Exercise Duration influences IL-1β levels
Cox et al., 2007 performed a series of trials with 18 well trained males. There was a 30
min trial at 60% VO2max, a 60 min trial at 65% VO2max, and an interval trial with 6 sets of 3
min running at 90% VO2max. The long trial was found to increase IL-6 by 527.1% compared to
65.1% (interval trial) and 42.8% (30 min trial) (Cox, Pyne, Saunders, Callister, & Gleeson,
2007). This would suggest that duration is a key determinant in the level of inflammatory
response. A number of studies have attempted to induce inflammation using a short duration (25 min) plyometric workout, but have failed to show any significant increases in IL-1β
(Chatzinikolaou et al., 2010; Isaacs, 2012; Tofas et al., 2008). The magnitude of injuries in these
plyometric studies is often very small and in some cases fails to significantly alter muscle
function (Chatzinikolaou et al., 2010; Tofas et al., 2008). Studies with longer injury protocols,
from 45 min (Cannon et al., 1989; Evans et al., 1986; Pournot et al., 2011), 60 min (Haahr et al.,
1991; J. P. Scott et al., 2013), and longer (Ostrowski, Rohde, Zacho, et al., 1998; Sprenger et al.,
1992) have shown significant elevations in IL-1β suggesting that longer protocols may induce
more inflammation. However, results have been inconsistent with manipulating duration alone
with other studies showing no change after an hour of downhill running (L. L. Smith et al.,
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2007). The literature as a whole suggests that longer duration protocols tend to produce
significant elevations of plasma IL-1β, but shorter protocols do not.

Differential effects of whole body vs single joint exercise on IL-1β levels
Isolated single joint exercises produce significantly less inflammation than whole body
endurance exercise protocols (J. M. Peake, K. Suzuki, M. Hordern, et al., 2005; J. M. Peake, K.
Suzuki, G. Wilson, et al., 2005; Petersen et al., 2001; L. Smith et al., 2000; Thompson et al.,
2004). Taken together, these studies suggest that the amount of muscle mass involved in the
injury is important to the magnitude of the inflammatory response. Specifically, the greater the
amount of muscle involved in the injury, the larger the inflammatory response will be (see Table
1.1).

Table 1.1. Summary of different injury protocols and their resultant inflammatory markers
Study

IL-1β

Protocol

Time Length training status

Sample size MVC Change

IL-6

Sprenger et al., 1992

20 km run (95-120 min)

trained (large
95-120 min range)

n = 22

3 fold peak increase in plasma Urine levels elevated 3, 7 and 24 hrs
returned to baseline in 24 hours post exercise

Chatzinikolaou et al., 2010

50 hurdle jumps, 50 drop jumps

short

52.1±6.4

n = 12

No significant change
detected

Tofas et al., 2008

96 hurdle jumps, 96 box jumps

2-5 min

untrained

n = 18

No significant change
detected

Isaacs AW, 2012

10 sets of 10 high jumps

short

untrained

n = 39

Pournot et al., 2011

Simulated Trail run up to 80%
VO2max

45 min

62±1.18

n= 8

Significantly elevated 1 h post exercise

Cannon et al., 1989

45 min downhill run 16% incline
75% VO2max

45 min

n= 5

Elevated intramuscular levels up to 5
days

Smith et al., 2007

60 min downhill run 13.5% incline 60 min

Evans et al., 1986

45 min eccentric cycling 250 W

Ostrowski et al., 1998

Copenhagen Marathon run time
3:17:03 ± 00:07:39

~197±7min 58.8

n = 16

Haahr et al., 1991

200W for 60 min

60 min

43.1-59.7

n = 10

Vyver et al., 2013

12X5 min 15km/h 10% grade

60 min

50.7±1.1

n = 18

Scott et al., 2013

60min @ 60% run to exhaustion
@ 75%

~2 hrs

67.9-55.5

n = 10

47.1±3.6

n = 10

2 fold increase at 24 hours

Undetectable expect immediately post
exercise

Slight significant increase

Up to 29 pg/mL

No change detected
Elevated 3h post exercise in untrained
males

45 min
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Significant increase from
1.5±0.7 pg/mL to 94.4±12.6
pg/mL

Significant increase from 0.61±0.24
pg/mL to 0.92±0.26 pg/mL
immediately post exercise
Significantly elevated 2h post exercise

2 fold increase for 4 hours

No Change detected

2.5 fold increase end of exercise

Mechanism of Fatigue in an Uninjured Muscle Following Eccentric Injury of Another Muscle
Group
The studies above provide evidence that eccentrically biased exercise of sufficient
duration and intensity could be communicated to the central nervous system via inflammation.
Prior studies suggest that longer duration, high intensity exercise can lead to elevated circulating
pro-inflammatory cytokines. There is evidence that acute inflammation is communicated to the
central nervous system via two avenues: sensitization and activation of group IV afferents, and
activation of brain macrophage like cells which in turn secrete inflammation directly into the
brain. Sensitization of the group IV afferents can lead to a reduction in MVC by reducing the
number of recruited motor units. The areas of the brain affected involve the cortex and
subcortical regions which may also affect motor unit recruitment by altering the excitability of
the motor cortex. The evidence also suggests that the Substantia Nigra, or the reward center of
the brain is specifically activated and may sensitize the brain to fatigue. Taken together, it is
possible that inflammation from exercise induced muscle injury results in decreased peak torque
and voluntary activation for 24-48 h post injury, but these ideas have never been directly tested.
Two key questions need to be addressed. First, is the CNS’s ability to activate uninjured muscle
affected after an acute muscle injury? If the answer to this question is yes, the second question
that needs to be addressed is whether inflammatory cytokines are related to any changes
observed in CNS function? This review suggests that such information could be communicated
via circulating pro-inflammatory cytokines.
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CHAPTER TWO
INTRODUCTION
Skeletal muscle injury often occurs following novel or intense eccentric muscle actions.
This injury can lead to functional deficits in the muscle which are disproportionate to the extent
of physical damage within the muscle fiber (Warren, Ingalls, Lowe, & Armstrong, 2002). It is
generally accepted that muscle injury leads to a loss of force production due to physical
disruptions of the force generating structures within the cell, and the structures involved in
transmitting signals from the nerve into the interior of the cell, also known as excitation
contraction (E-C) uncoupling (Warren et al., 2002). In a mouse model of muscle injury, E-C
uncoupling accounts for most of the early force loss (0-3 days) after injury, whereas a frank loss
of contractile proteins becomes more prominent 3-28 days after injury (Warren et al., 2002).

The strength of a given muscle depends upon the size of the muscle, the number of
actomyosin cross bridges, and the level of activation from the central nervous system (Frontera
& Ochala, 2015), among other factors. There is evidence that skeletal muscle injury results not
only in a reduced intrinsic force producing capability, but also impairment of activation of the
injured muscle (Behrens, Mau-Moeller, & Bruhn, 2012; Deschenes et al., 2000; Komi &
Viitasalo, 1977). This suggests that information of the injury is communicated to the central
nervous system (CNS), which then alters motor unit recruitment or rate coding. This information
could be transmitted to the central nervous system via two separate mediums.

The first medium capable of transmitting this information is blood. Muscle injury results
in the release of numerous intracellular proteins into systemic circulation (McKune, Semple, &
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Peters-Futre, 2012). This is thought to result in elevated pro-inflammatory cytokines in the
systemic circulation (Nieman et al., 1998; Suzuki et al., 2002). Previous studies suggest that proinflammatory cytokines in circulation can communicate exercise-induced muscle injury to the
brain, resulting in reduced CNS function (Carmichael et al., 2005; Carmichael et al., 2006).
Since this medium would not convey the specific location of the injury to the central nervous
system, any effects would likely be widespread throughout the body.

The second medium that could transmit information of muscle injury to the central
nervous system is afferent nerves. Group III/IV afferent nerves have been shown to relay
information of muscle fatigue to the central nervous system, resulting in reduced activation of
both the working muscle (Amann & Dempsey, 2008; Amann, Proctor, Sebranek, Pegelow, &
Dempsey, 2009), and muscles distant from the site of fatigue (Sidhu et al., 2014). Group IV
afferent nerves are thought to be sensitized following muscle injury by pro-inflammatory
cytokines retained within the injured muscle (Marqueste et al., 2004).

This study had three main objectives. The first objective was to determine whether
exercise-induced muscle injury could affect the strength of a muscle distant from the site of
injury. The second objective was to determine whether any dysfunction in the distant muscle
was due to reductions in CNS function, and the third was to examine whether plasma cytokines
were related to any changes observed. Answering these questions improves our understanding of
the CNS’s role following muscle injury, and could lead to insights of mechanisms contributing to
widespread neuromuscular dysfunction.
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PROCEDURES
Study Design

The overall design of this study was to induce injury in leg muscles with a downhill
running protocol in a set of subjects, and to determine whether injury of the knee extensors
affected subsequent function of uninjured elbow flexor muscles. Measurements of strength and
activation of knee extensors and elbow flexors were taken before, 15 min, 24 h, and 48 h after
downhill running. Subjects then performed a fatigue protocol with the knee extensor and elbow
flexor muscles to examine how strength and activation following muscle injury are impacted in a
fatigued state. Urine and blood samples were taken pre, post, 24 h post, and 48 h post injury to
assess markers of inflammation. A control group did not undergo the injury protocol, but
provided strength and activation measurements of the knee extensors and elbow flexors over the
same time period for comparison (Warren, Hermann, Ingalls, Masselli, & Armstrong, 2000). For
a summary of the procedures see Figure 2.1.

Fig 2.1. An outline of the testing protocol. KE IT refers to the Knee Extensor Interpolated
Twitch. EF IT refers to the Elbow Flexor Interpolated Twitch. Urine and blood samples were
stored and measured for IL-1β content.
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Subjects
Recreationally active subjects who were not specifically training for running were
recruited for this study. Based on a health history form, subjects who either failed to meet the
ACSM guidelines for low risk (Thompson, Gordon, & Pescatello, 2009), ran more than 10 miles
per week, or participated in plyometric training were excluded from testing. A power analysis
was performed using G-power 3.1 (Universitat Kiel, Germany) for a repeated measures ANOVA
on biceps MVC peak force. The effect size was estimated at .2, and the correlation of repeated
measures estimated at .9 giving an estimated sample size of 14. The measured effect in the
elbow flexors was larger than estimated (ղ2 ≥ 0.241) allowing for a smaller sample size of 12
subjects, while maintaining statistical power. For a summary of subject characteristics see Table
2.1.

Table 2.1 Subject Characteristics
Injury (n = 6)

Control (n = 6)

VO2peak (ml/kg/min)

49.2 ± 12.18

44.2 ± 6.98

Height (cm)

175.6 ± 6.05

174.4 ± 12.28

Weight (kg)

80.2 ± 5.44

73.3 ± 13.66

Age (yr)

27.3 ± 7.69

27.6 ± 8.48

Values are mean ± SD.
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Screening Trial
Subjects reported to the Applied Physiology Lab for testing. Subjects first provided their
informed consent, and then filled out a health history form to ensure all subjects were low risk
according to the ACSM risk stratification procedures (Thompson et al., 2009). Subjects were
then escorted to a separate lab containing a Kin-Com III (Chattecx: Chattanooga, TN) and asked
to perform a practice set of the twitch interpolation and fatigue inducing procedures for the knee
extensors and elbow flexors. Subjects that failed to demonstrate an ability to adequately perform
the twitch interpolation procedure were excluded from further testing. Subjects were then
weighed without shoes and asked to perform a graded exercise test (Appendix 5). Gas exchange
variables were measured throughout the test using a True Max 2400 Metabolic Measurement
System (Parvomedics: East Sandy, UT). The highest 15 second average of VO2 was used as the
subject’s VO2peak. Subjects were then scheduled for the remaining testing sessions. The injury
protocol took place within 1-2 weeks of the subject’s screening trial.

Injury Protocol
Subjects were asked to run downhill on a treadmill for one hour to injure the knee
extensor muscles. A downhill run at 10% grade for 60 minutes at a speed equivalent to 75% of
VO2peak at 0% grade was selected to induce injury because this protocol resulted in a significant
injury, produced a large inflammatory response, and could be employed with untrained subjects
(McKune, Smith, Semple, Mokethwa, & Wadee, 2006; Smith et al., 2007).
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Twitch Interpolation Protocol
Twitch interpolation was used to quantify changes in voluntary muscle activation to
determine whether changes in strength were due to the inability to maximally activate skeletal
muscle, ie., central fatigue. A constant current, high voltage Digitimer DS7AH stimulator
(Digitimer: Hertfordshire, UK) was used to stimulate the elbow flexor and knee extensor
muscles. To test the elbow flexor muscles, the subjects were seated in a CB-6 Arm Curl Bench
(Valor Fitness: St. Petersburg, FL) in close proximity to a Kin-com III set up to measure torque
at 90° of elbow flexion. To test the knee extensors, subjects were seated in a Kin-com III set up
in the standard configuration to measure knee extensor torque (Manual) with 110⁰ of hip flexion
and 70⁰ of knee flexion. The subject’s leg, chest, and waist were strapped down for knee
extensor measurements. The placement of the seat, lever arm and servo-motor were recorded to
standardize within subject measurements between trials. A constant current, high voltage
Digitimer DS7AH stimulator (Digitimer: Hertfordshire, UK) was used to stimulate the knee
extensors and elbow flexors. Stimulation electrodes (UniPatch 6696SS, Wabasha, MN) were
placed over the proximal belly and the distal tendon of the biceps for elbow flexor measurements
(Magnus, Barss, Lanovaz, & Farthing, 2010). Stimulation electrodes (UniPatch 617SB,
Wabasha, MN) for the knee extensors were placed over the distal vastus medialis muscle and the
proximal vastus lateralis muscle near the anterosuperior iliac spine. For continuity, the position
of the electrodes was outlined in permanent marker (Park et al., 2008). A series of control
twitches was delivered to the muscle starting at 60mA for the elbow flexors, 100mA for the knee
extensors, and increased by 20 mA, until two consecutive increases in amperage failed to
increase the peak torque of the twitch. This current was recorded and used throughout the trial to
stimulate the muscle. (Magnus et al., 2010; Park et al., 2008).
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The subjects were asked to perform a 3 second maximal voluntary contraction (MVC),
and an electrical stimulation was applied 2.5 seconds into the contraction. Two paired stimuli
were then applied to the muscle at 2 and 4 seconds after the MVC; the resultant torque was
averaged and used for analysis. The subjects performed this procedure six times, with 1 minute
of rest between contractions. The three interpolated twitch measurements with the highest force
were selected and averaged to determine resting voluntary activation. Voluntary activation was
estimated using the following equation: Voluntary Activation percentage = (1 – Superimposed
Twitch Torque / Control Twitch Torque) X 100 (Allen, Gandevia, & McKenzie, 1995). The
interpolated twitch technique is depicted graphically in Figure 2.2.

Figure 2.2. A visual representation of the interpolated twitch procedure. Representative force
tracing shows a 3 second MVC with twitch interpolation procedure. The resultant twitch height
during the MVC contraction is compared the twitch height while the muscle is relaxed to
determine the level of activation in the muscle.

47

Fatigue Protocol

A procedure to fatigue the elbow flexors and the knee extensors was conducted in a
similar fashion to the procedure described previously in the literature (Collier, Hardy, MillardStafford, & Warren, 2015). Subjects performed five sets of 10 isotonic concentric contractions
of the knee extensors or elbow flexors on a KinCom III dynamometer. Subjects were given 5 s
of rest between contractions and 20 s of rest between sets. For elbow flexor testing, the
concentric action was done at 30⁰/s over a 75⁰ range beginning at maximal extension (Hansen,
1967). For knee extensor testing, the concentric action was done at 30⁰/s over a 45⁰ range
beginning at 90⁰ flexion. The isotonic load was set at 55% of peak force for each day. The
subject was required to complete each contraction, and if unable to complete a contraction the
researchers provided the minimum amount of assistance needed to complete the contraction.

Urine Samples

Urine samples were collected prior to other pre-injury measurements, 2 h post injury, 24
h post injury, and 48 h post injury. The time frame of the urine samples was chosen based on
previous research showing that IL-1β has a delayed appearance in the urine of 3 h after the start
of exercise (Sprenger et al., 1992). Immediately after collection, a 5 ml sample of the urine was
centrifuged at 1,000g for 10 min at 4⁰ C to remove leukocytes and debris (de Reijke, de Boer,
Kurth, & Schamhart, 1996; Thomas, Sexton, Benson, Sutphen, & Koomen, 2010). The
centrifuged urine samples were then apportioned into 1.5 ml aliquots for freezing and storage at
-80 ⁰ C for later analysis.
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Blood Samples
Blood samples were collected via venipuncture prior to other pre-injury measurements,
immediately post injury, 24 h post injury, and 48 h post injury. Blood samples were drawn into
4 mL Vacutainers (BD: Franklin Lakes, NJ) treated with 7.2 mg of EDTA.

The blood was

centrifuged under refrigeration at 2,000 x g for 15 minutes. The plasma sample was then
transferred to a clean tube and apportioned into 1.5 mL aliquots for storage at -80⁰ C for future
analysis (Smith et al., 2007).

Determination of Plasma IL-1β content
IL-1β levels were measured in plasma samples using an ultra-sensitive ELISA kit (Life
Technologies Corp.: Frederick, MD) with a range of 0.3 to 20 pg/mL and a sensitivity of < 1
pg/mL. The following procedure was used for quantifying IL-1β content: 50 μL of incubation
buffer was added to each well, except for chromogen blank wells. Researchers added 100 μL of
samples or controls to their appropriate wells. The plate was then covered and allowed to
incubate at room temperature for 3 h. The liquid in the wells was then removed and each well
was washed 4 times. Then 100 μL of biotin conjugate was added to all wells except the
chromogen blanks. The plate was then covered and allowed to incubate at room temperature for
1 h. The liquid in the wells was then removed and each well was washed 4 times. Then 100 μL
of Streptavidin-HRP working solution was added to each well except the chromogen blanks.
The plate was then covered and allowed to incubate for 30 min at room temperature. The liquid
in the wells was then thoroughly removed and washed 4 times. Researchers added 100 μL of
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stabilized chromogen to each well, which began to turn blue in color. The plate was then
incubated for 30 min. Then 100 μL of stop solution was added to each well and the color
changed from blue to yellow. The absorbance was read using a 450 nm filter after blanking the
plate reader against the chromogen blanks. The absorbance of the standards was used to create a
standard curve, which was used to determine the IL-1β concentrations for the unknown samples.

Determination of Plasma TNF-α content
TNF-α levels were measured in plasma samples using an ultra-sensitive ELISA kit (Life
Technologies Corp.: Frederick, MD) with a range of 0.5 to 32 pg/mL. The following procedure
was used for quantifying TNF-α content: Either 100 μL controls or 50 μL of standard diluent
buffer and 50 μL of sample was added to the appropriate wells, except for chromogen blank
wells. Then 50 μL of biotin conjugate was added to each well except the chromogen blanks.
The plate was then covered and allowed to incubate at room temperature for 3 h. The liquid in
the wells was then removed and each well was washed 4 times. Researchers added 100 μL of
Streptavidin-HRP working solution to each well except the chromogen blanks. The plate was
then covered and allowed to incubate for 30 min at room temperature. The liquid in the wells
was then removed and the plate was washed 4 times. Then 100 μL of stabilized chromogen was
added to each well, which began to turn blue in color. The plate was then allowed to incubate
for 30 min. Researchers added 100 μL of stop solution to each well and the color changed from
blue to yellow. The absorbance was read using a 450 nm filter after blanking the plate reader
against the chromogen blanks. The absorbance of the standards was used to create a standard
curve, which was used to determine the TNF-α concentrations for the unknown samples.
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Measuring Subjective Pain
Subjects were given two visual analog scales labeled “Thigh Pain” and “Upper Arm
Pain”. Then subjects were asked to rate their current level of pain at rest using a tick mark to
indicate on a scale of 0-100 mm. A score of 0 mm was labeled as “No Soreness” and a score of
100 mm was labeled as “Very, Very Sore”. The tick marks were then measured and recorded for
future analysis (Cleather & Guthrie, 2007).

Upper Arm and Thigh Circumference
Sites for standard upper arm and thigh circumference measurements were located on the
subjects based the ACSM guidelines (Thompson et al., 2009). A standard Gulick Measurement
tape was used for all measurements. Circumferences were then recorded in cm. Three
measurements were taken at each site during every trial (pre-injury, immediate post-injury, 24 h
post-injury, and 48 h post-injury). The average of these three measurements was used for data
analysis.

Statistics
All statistical analysis was performed using SPSS version 24 (IBM: Armonk, NY) with a
significance level of 0.05. Values in the results are reported as means ± SEM. A set of two-way
repeated measures ANOVAs were conducted for both the resting conditions on the following
variables: knee extensors strength, knee extensors voluntary activation, knee extensors
electrically evoked force, elbow flexors strength, elbow flexors voluntary activation, elbow
flexors electrically evoked force, plasma IL-1β, plasma TNF-α, thigh pain, thigh circumference,
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upper arm pain, and upper arm circumference with 4 within factor measurements (pre, post, 24 h
post and 48 h post) and a between factor (injury vs control). separate two-way repeated
measures ANOVAs were conducted for both the resting and fatigued conditions on the following
variables: knee extensors strength, knee extensors voluntary activation, knee extensors
electrically evoked force, elbow flexors strength, elbow flexors voluntary activation, elbow
flexors electrically evoked force with 4 within factor measurements (pre, post, 24 h post and 48 h
post) and a between factor (rested vs fatigued). If the assumptions of sphericity were violated,
then a Huynh-Feldt correction was applied. When significant interactions were detected a simple
main effects test with a Benjamini & Hochberg false discovery rate correction was used to
determine where the differences lay.
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RESULTS
Subjects
A total of 12 subjects completed the research protocol. One additional subject completed the
entire procedure but was later excluded from the results due to an inability to complete the
downhill running protocol.

Overall Findings
Knee extensor strength was significantly reduced by 53.5 ± 9.9%, 46.0 ± 7.0% and 44.6 ± 8.1%
immediately, 24h and 48h after 1 h of downhill running, respectively (P ≤ 0.006). Knee extensor
electrically stimulated strength was significantly reduced 49.7 ± 7.7%, 30.8 ± 6.3%, and 27.4 ± 6.8%,
immediately, 24h and 48 h after the downhill run, respectively. There was a 23.4 ± 7.9%, 25.8 ± 8.8%
and 24.5 ± 7.9% change in activation of the knee extensors immediately, 24h and 48 h after the downhill
run, but these changes were not significant (P ≥ 0.075). Elbow flexor strength was significantly reduced
by 13.2 ± 3.9%, 17.3 ± 4.0%, and 9.0 ± 3.3% immediately, 24h and 48h after the downhill run (P =
0.019). Elbow flexor activation was reduced by 16.2 ± 5.1%, 20.9 ± 6.7%, and 12.9 ± 4.5% in the injury
group, but these changes were only different when compared to the control group (P = 0.045).
Electrically stimulated force was not impaired in the elbow flexors following the downhill run (P =
0.631). Plasma IL-1β (P = 0.235) and TNF-α (P = 0.456) were not different in the injury group when
compared with the control group.

MVC Strength of the Knee Extensor Muscles
Knee extensor strength prior to the fatiguing protocol was not different at rest between the control
and injury groups (P = 0.533). In the control group, there was no significant change in knee extensor
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strength from baseline at any timepoint (P > 0.394). After 1 h of downhill running, the injury group
experienced an immediate decline in strength relative to the preinjury values (P < 0.001). Strength in the
injury group was significantly reduced below baseline for 48 h (P < 0.001). Decline in force for 48 h
after the downhill run indicates muscle injury. The changes in knee extensor strength are depicted below
in Figure 2.3.
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Figure 2.3. Knee extensor force in relation to an injury inducing downhill run. Subjects (n = 12)
performed MVCs at the indicated time points in relation to a 1 h lower body injury inducing
downhill run. Strength was normalized to pre-injury values. Knee extensor force was found to
be significantly reduced at all time points after injury (P < 0.05) when compared to control.
Significant effects are denoted with (*).
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In the control group, knee extensor strength was compared in the rested and fatigued
states. Overall, there was a 17.3 ± 9.8% change in strength following the fatigue protocol, but
this change was not found to be significant (P = 0.108). No significant changes in strength
occurred over time (P = 0.762). The changes in control group knee extensor strength are
depicted in Figure 2.4.
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Figure 2.4. Knee extensor strength normalized to non-fatigued pre-injury values of the control
group before and after a fatiguing protocol in relation to an injury inducing downhill run.
Subjects (n = 6) performed MVCs immediately after a fatiguing protocol at the indicated time
points in relation to a 1 h lower body injury inducing downhill run. Knee extensor force was not
found to be significantly different based on fatigue within the control group (P = 0.108). Values
are reported as mean ± SEM.
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In the injury group, knee extensor strength was compared in the rested and fatigued
states. Overall, there was a significant 45.3 ± 5.7% change in strength following the injury
protocol, which persisted for up to 48 h (P < 0.001). Compared with the rested values, there was
an overall change of 9.7 ± 4.9% following the fatigue protocol, but this change was not
significant (P = 0.075). The changes in control group knee extensor strength are depicted in
Figure 2.5.
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Figure 2.5. Knee extensor strength of the injury
group before and after a fatiguing protocol in
X Data
relation to an injury inducing downhill run. Subjects (n = 6) performed MVCs immediately after
a fatiguing protocol at the indicated time points in relation to a 1 h lower body injury inducing
downhill run. Strength was normalized to non-fatigued pre-injury values. Knee extensor force
was found to be significantly lower than pre-injury values at all time points post-injury (P <
0.025). Significant effects are denoted with (*). Values are reported as mean ± SEM.
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Twitch Force of the Knee Extensor Muscles
Knee extensor electrically stimulated strength was not different between the control and
injury groups prior to the downhill run (P = 0.549). There was no change across any time point
in electrically stimulated force over time relative to the pre-injury values for the control group (P
≥ 0.293). The electrically evoked strength relative to the pre-injury values was significantly
reduced immediately (P = 0.010) and 24 h post-injury (P = 0.022), but the strength loss was no
longer significantly reduced by 48 h post-injury (P = 0.091). The changes in knee extensor
electrically stimulated force are depicted in Figure 2.6.
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Figure 2.6. Knee extensor electrically stimulated force at rest in relation to an injury inducing
downhill run normalized to pre-injury twitch force at rest. Knee extensor electrically stimulated
force was measured in subjects (n = 11) immediately prior to a fatiguing protocol was performed
using the interpolated twitch technique at the indicated time points in relation to a 1 h lower body
injury inducing downhill run. Strength was normalized to pre-injury values. Knee extensor
electrically stimulated force at rest was found to be significantly reduced at 24 h post-injury (P =
0.010) and 48 h post-injury (P = 0.022) compared to control. Significant effects are denoted with
(*). Values are reported as mean ± SEM.
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In the control group, knee extensor electrically simulated strength was compared between
the rested and fatigued states. Overall, there was a 1.3 ± 7.7% change in electrically stimulated
strength following the fatigue protocol, but this change was not found to be significant (P =
0.872). Significant changes in electrically stimulated strength occurred over time (P = 0.004),
but post-hoc testing did not detect differences at any time point. There was no significant
interaction (P = 0.841). The changes in knee extensor electrically stimulated force following a
fatiguing protocol are depicted below in Figure 2.7.
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Figure 2.7. Knee extensor electrically stimulated strength between the rested and fatigued state
in the control group in relation to an injury inducing downhill run normalized to pre-injury
twitch force at rest. Subjects (n = 6) performed the interpolated twitch technique at the indicated
time points in relation to a 1 h lower body injury inducing downhill run before and after a
fatiguing protocol. Strength was normalized to non-fatigued pre-injury values. Knee extensor
electrically stimulated strength was found to be significantly affected by time (P = 0.004), but
post-hoc testing failed to find any differences (P > 0.125). Values are reported as mean ± SEM.
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In the injury group, knee extensor electrically simulated strength was compared between
the rested and fatigued states. Values were normalized to the rested pre-injury measurements.
Overall, there was a 2.5 ± 6.7% change in electrically stimulated strength following the fatigue
protocol, but this change was not found to be significant (P = 0.721). Significant changes in
electrically stimulated strength occurred over time (P = 0.004), but with no significant interaction
(P = 0.841). Overall, the twitch strength declined significantly immediately post-injury 43.2 ±
5.6%. Twitch strength partially recovered at 24 h to a 26.2 ± 6.8% and remained only partially
recovered at 48 h. The changes in knee extensor electrically stimulated force following a
fatiguing protocol are depicted below in Figure 2.8.
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Figure 2.8. Knee extensor electrically stimulated force between the rested and fatigued state in
the injury group in relation to an injury inducing downhill run normalized to pre-injury twitch
force at rest. Subjects (n = 5) performed the interpolated twitch technique at the indicated time
points in relation to a 1 h lower body injury inducing downhill run before and after a fatiguing
protocol. Strength was normalized to non-fatigued pre-injury values. Knee extensor electrically
stimulated force was found to be significantly reduced overall immediately at all time points
after the injury (P < 0.030). Significant between group effects are denoted with (*). Values are
reported as mean ± SEM.
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Voluntary Activation of the Knee Extensor Muscles

Knee extensor voluntary activation measured prior to a fatiguing protocol was found to
have a significant interaction (P = 0.047) but post-hoc testing failed to detect any significant
differences. One subject was excluded from this analysis due to an inability to tolerate current
stimulations above 200 mA. The knee extensor activation prior to a fatiguing protocol over time
is depicted below in Figure 2.9.
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Figure 2.9. Knee extensor activation in relation to an injury inducing downhill run. Subjects (n
= 11) performed the interpolated twitch technique to measure voluntary activation at the
indicated time points in relation to a 1 h lower body injury inducing downhill run. Knee extensor
activation was found to be significantly reduced overall based on time (P = 0.049), but post-hoc
analysis failed to detect any differences. Values are reported as mean ± SEM.
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In the control group, knee extensor voluntary activation was compared between the rested
and fatigued states. Overall, there was a significant 13.7 ± 4.9% change in electrically
stimulated strength following the fatigue protocol (P = 0.019). No significant changes occurred
in activation over time (P = 0.986). The changes in knee extensor electrically stimulated force
following a fatiguing protocol are depicted below in Figure 2.10.
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Figure 2.10. Knee extensor activation between the rested and fatigued state in the control group
relation to an injury inducing downhill run. Subjects (n = 6) performed the interpolated twitch
technique to measure voluntary activation at the indicated time points in relation to a 1 h lower
body injury inducing downhill run. Knee extensor activation was found to be significantly
reduced overall based between the rested and fatigued states (P = 0.019), but no changes
occurred over time (P = 0.986). Values are reported as mean ± SEM.
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Knee extensor voluntary activation was compared between the rested and fatigued states
in the injury group. Overall, there was a 13.2 ± 11.5% change in activation following the fatigue
protocol, but this was not found to be significant (P = 0.285). Significant changes occurred in
activation over time (P = 0.003), but there was no significant interaction (P = 0.648). The
changes in knee extensor electrically stimulated force following a fatiguing protocol are depicted
below in Figure 2.10.
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Figure 2.11. Knee extensor activation between the rested and fatigued state in the injury group
in relation to an injury inducing downhill run. Subjects (n = 5) performed the interpolated twitch
technique to measure voluntary activation at the indicated time points in relation to a 1 h lower
body injury inducing downhill run. Knee extensor activation was found to be significantly
reduced immediately post-injury (P = 0.023). Significant effects are denoted with (*). Values
are reported as mean ± SEM.
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MVC Strength of the Elbow Flexor Muscles
Prior to the downhill run there was no significant difference in resting elbow flexor
strength between the injury and control groups (P = 0.715). There were no significant changes
from pre-injury strength in the control group, but the injury group was significantly reduced
immediately, and 24 h post-injury. For a summary of results, see Figure 2.12.

Figure 2.12. Elbow flexor force normalized to pre-injury values in relation to an injury inducing
downhill run. Subjects (n = 12) performed MVCs at the indicated time points in relation to a 1 h
lower body injury inducing downhill run. Strength was normalized to pre-injury values. Elbow
flexor force was found to be significantly reduced in the injury group immediately, and 24 h
post-injury. Significant between group effects are denoted with (*). Values are reported as mean
± SEM.
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In the control group, elbow flexor MVC strength was compared between the rested and
fatigued states. Overall, there was a significant 27.4 ± 4.1% reduction in strength following the
fatigue protocol (P < 0.001). No significant changes occurred in strength over time (P = 0.451).
The changes in elbow flexor MVC strength are depicted below in Figure 2.13.
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Figure 2.13. Elbow flexor force normalized to non-fatigued pre-injury values between rested
and fatigued states in the control group in relation to an injury inducing downhill run. Subjects
(n = 6) performed MVCs immediately after a fatiguing protocol at the indicated time points in
relation to a 1 h lower body injury inducing downhill run. Strength was normalized to nonfatigued pre-injury values. Elbow flexor force was significantly lower in the fatigued state
compared to the rested state (P < 0.001), but no significant changes occurred over time (P =
0.451). Values are reported as mean ± SEM.
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Elbow flexor muscle MVC strength was compared between the rested and fatigued states
in the injury group. Overall, there was a significant 23.7 ± 4.2% reduction in strength following
the fatigue protocol (P < 0.001). No significant changes occurred in strength over time (P =
0.154). The changes in elbow flexor MVC strength are depicted below in Figure 2.14.
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Figure 2.14. Elbow flexor force normalized to non-fatigued pre-injury values between rested
and fatigued states in the injury group in relation to an injury inducing downhill run. Subjects (n
=12) performed MVCs immediately after a fatiguing protocol at the indicated time points in
relation to a 1 h lower body injury inducing downhill run. Strength was normalized to nonfatigued pre-injury values. Elbow flexor force was significantly lower after the fatiguing
protocol (P < 0.001), but no significant changes occurred over time (P = 0.154). Values are
reported as mean ± SEM.

65

Elbow Flexor Electrically Stimulated Force
Prior to the downhill run, there was no difference in electrically stimulated force
measured prior to a fatigue protocol between the control and injury groups (P = 0.820). No
significant changes occurred in elbow flexor electrically stimulated force relative to pre-injury
values over time (P = 0.539). No changes were observed in electrically stimulated force
between the injury and control groups (P = 0.187). The elbow flexor electrically stimulated force
at rest data is depicted below in Figure 2.15.
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Figure 2.15. Elbow flexor electrically stimulated force at rest in relation to an injury inducing
downhill run normalized to pre-injury twitch force at rest. Subjects (n = 12) performed the
interpolated twitch technique at the indicated time points in relation to a 1 h lower body injury
inducing downhill run to measure elbow flexor electrically stimulated force immediately prior to
a fatiguing protocol. Elbow flexor electrically stimulated force was not found to be significantly
different at any time point (P ≥ 0.268). Values are reported as mean ± SEM.
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In the control group, elbow flexor muscle electrically simulated strength was compared
between the rested and fatigued states. Overall, there was a 15.4 ± 9.4% change in electrically
stimulated strength following the fatigue protocol, but this change was not found to be
significant (P = 0.131). No significant changes in electrically stimulated strength occurred over
time (P = 0.095), and there was not a significant interaction (P = 0.771). The changes in elbow
flexor muscle electrically stimulated strength in the control group are depicted below in Figure
2.16.
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Figure 2.16. Elbow flexor electrically stimulated force between the rested and fatigued states in
the control group in relation to an injury inducing downhill run normalized to pre-injury twitch
force at rest. Subjects (n = 6) performed the interpolated twitch technique at the indicated time
points in relation to a 1 h lower body injury inducing downhill run to measure elbow flexor
electrically stimulated force immediately prior to a fatiguing protocol. Elbow flexor electrically
stimulated force was not found to be significantly different at any time point (P ≥ 0.095). Values
are reported as mean ± SEM.
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Elbow flexor muscle electrically simulated strength was compared between the rested
and fatigued states in the injury group. Overall, there was a significant 24.4 ± 7.2% change in
electrically stimulated strength following the fatigue protocol (P = 0.007). No significant
changes in electrically stimulated strength occurred over time (P = 0.798), and there was not a
significant interaction (P = 0.704). The changes in elbow flexor muscle electrically stimulated
strength in the injury group are depicted below in Figure 2.17.
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Figure 2.17. Elbow flexor electrically stimulated force between the rested and fatigued states in
the injury group in relation to an injury inducing downhill run normalized to pre-injury twitch
force at rest. Subjects (n = 6) performed the interpolated twitch technique at the indicated time
points in relation to a 1 h lower body injury inducing downhill run to measure elbow flexor
electrically stimulated force immediately prior to a fatiguing protocol. Elbow flexor electrically
stimulated strength was overall reduced in the fatigue measurements (P = 0.007). Values are
reported as mean ± SEM.
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Elbow Flexor Activation
Voluntary activation in the elbow flexors prior to a fatiguing protocol was not different
between the control and injury groups prior to the downhill run (P = 0.682). Activation did not
significantly change over time in the control group. Immediately post-injury there was a 16.2 ±
5.1% change in voluntary activation in the elbow flexors, but this was not found to be
significant. By 24 h the elbow activation had declined to 20.9 ± 6.7%, and remained
significantly reduced at 48 h post-injury when compared to controls. The changes in voluntary
activation over time by group are depicted below in Figure 2.18.
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Figure 2.18. Elbow flexor activation in relation to an injury inducing downhill run. Elbow
flexor voluntary activation was measured using the interpolated twitch technique at the indicated
time points in relation to a 1 h lower body injury inducing downhill run. Elbow flexor activation
was found to be significantly reduced 24 h (P = 0.030) and 48 h (P = 0.039) post-injury when
compared to control. Significant effects are denoted with (*). Values are reported as mean ±
SEM.
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Voluntary activation of the elbow flexor muscles was compared between the rested and
fatigued states in the control group. Overall, there was a significant 10.8 ± 3.3% reduction
between rested and fatigued states (P = 0.009). However, there was not found to be significant
time (P = 0.551) or interaction effects (P = 0.143). Voluntary activation of the elbow flexors in a
fatigued state is depicted below in Figure 2.19.
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Figure 2.19. Elbow flexor activation between rested and fatigued states in the control group in
relation to an injury inducing downhill run. Subjects (n = 12) performed the interpolated twitch
technique to measure elbow flexor activation before and after a fatiguing protocol at the
indicated time points in relation to a 1 h lower body injury inducing downhill run. Elbow flexor
activation was found to be significantly reduced in the fatigued state compared to the rested state
(P = 0.009). Values are reported as mean ± SEM.
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Voluntary activation of the elbow flexor muscles was compared between the rested and
fatigued states in the injury group. Overall, there was a significant 13.6 ± 9.5% change in
activation between rested and fatigued states, but this was not found to be significant (P = 0.184).
There was not found to be significant time (P = 0.291) or interaction effects (P = 0.092).
Voluntary activation of the elbow flexors in a fatigued state is depicted below in Figure 2.20.
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Figure 2.20. Elbow flexor activation between rested and fatigued states in the injury group in
relation to an injury inducing downhill run. Subjects (n = 12) performed the interpolated twitch
technique to measure elbow flexor activation before and after a fatiguing protocol at the
indicated time points in relation to a 1 h lower body injury inducing downhill run. Elbow flexor
activation was not found to be significantly reduced in the fatigued state compared to the rested
state (P = 0.184). Values are reported as mean ± SEM.
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Inflammatory Cytokines
Plasma IL-1β concentrations remained unchanged for both groups at all time point
observed (P > 0.235). For the majority of subjects tested, concentrations remained below the
threshold of detection (.3 pg/ml). The reliability of the assay was examined using a bivariate
correlation between the duplicate measures (R = 0.999, P < 0.001). Only 9 subjects were
included in this analysis due to availability of useable samples. Urine samples were not analyzed
due to a lack of funding. Plasma IL-1β concentrations over time are depicted below in Figure
2.21.
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Figure 2.21. Plasma IL-1β concentrations in relation to an injury inducing downhill run.
Subjects (n = 9) had blood drawn and measured using an ultra-sensitive ELISA kit at indicated
time points in relation to a 1 h lower body injury inducing downhill run. IL-1β was not found to
be significantly different between groups at any time points measured (P > 0.235). Values are
reported as mean ± SEM.
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There was no significant difference in plasma TNF-α concentrations between the control
and injury groups at any time point tested (P = 0.456). Compared with the pre-injury levels,
TNF-α concentrations were found to be significantly reduced in both groups immediately (P =
0.002) and 24 h post-injury (P = 0.048). Concentrations returned to baseline by 48 h (P = 0.702).
The reliability of the assay was examined using a bivariate correlation between the duplicate
measures (R = 0.991, P < 0.001). Only 5 subjects were included in this analysis due to
availability of useable samples. Urine samples were not analyzed due to a lack of funding.
TNF-α concentrations over time are depicted below in Figure 2.22.
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Figure 2.22. Plasma TNF-α concentrations in relation to an injury inducing downhill run.
Subjects (n = 5) had blood drawn and measured using an ultra-sensitive ELISA kit at indicated
time points in relation to a 1 h lower body injury inducing downhill run. TNF-α was found to be
significantly lower overall immediately (P = 0.002) and 24 h post-injury (P = 0.046) compared to
the pre-injury concentrations. Significant overall effects are denoted with (†). Values are
reported as mean ± SEM.
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Limb Pain
Thigh pain was not found to be different between the groups prior to the downhill run (P =
0.217). After the downhill run, thigh pain was significantly elevated in the injury group at all time points
measured (P ≤ 0.001). Only 10 subjects were included in this analysis due to missing data. The thigh
pain between groups over time is depicted below in Figure 2.23.
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Figure 2.23. Thigh pain in relation to an injury inducing downhill run. Subjects (n = 10)
estimated their thigh pain using a visual analog scale at indicated time points in relation to a 1 h
lower body injury inducing downhill run. Thigh pain was found to be significantly elevated in
the injury group at all time point (P < 0.001) when compared to control. Significant between
group effects are denoted with (*). Values are reported as mean ± SEM.
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Arm pain was not significantly different between the injury and control groups at any time point
(P ≥ 0.092). There was a significant time effect on Pain at 24 h (P = 0.049), but not at other time points
(P ≥ 0.077). Only 10 subjects were included in this analysis due to missing data. The upper arm pain
between groups over time is depicted below in Figure 2.24.

Figure 2.24. Upper arm pain in relation to an injury inducing downhill run. Subjects (n = 10)
rated their upper arm pain using a visual analog scale at indicated time points in relation to a 1 h
lower body injury inducing downhill run. Upper arm pain was found to be significantly elevated
overall at 24 h post-injury (P = 0.049), with no differences between injury and control groups (P
> 0.05). Significant overall effects are denoted with (†). Values are reported as mean ± SEM.
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Limb Circumference
Thigh circumference was significantly larger in the injury group at all time points compared with the
control group (P = 0.041). However, there were no changes in thigh circumference over time (P = 0.407).
The thigh circumference data is depicted in Figure 2.25.
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Figure 2.25. Thigh circumference in relation to an injury inducing downhill run. Subject (n =
10) thigh circumference was measured at indicated time points in relation to a 1 h lower body
injury inducing downhill run. Thigh circumference was not found to be significantly different at
any time point (P > 0.05).
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Arm circumference was not significantly different between the injury and control groups (P =
0.590), and did not change over time (P = 0.331). The upper arm circumference data is depicted in Figure
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Figure 2.26. Upper arm circumference in relation to an injury inducing downhill run. Subject (n
= 10) upper arm circumference was measured at indicated time points in relation to a 1 h lower
body injury inducing downhill run. Upper arm circumference was not found to be significantly
different at any time point (P > 0.05).
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DISCUSSION
Running downhill for one hour resulted in injury to the knee extensor muscles of recreationally
active individuals, impairing function for up to 48 h. This leg muscle injury was associated with a
reduction in elbow flexor strength immediately, and 24 h post injury (P = 0.010). These impairments
were not due to intrinsic changes of the elbow flexor muscles since no changes occurred in electrically
stimulated force (P = 0.539), but can be attributed to changes in elbow flexor activation beginning 24h (P
= 0.030) after the injury, with significant deficits in activation lasting up to 48 h (P = 0.039). No changes
were found in plasma IL-1β (P = 0.235) or plasma TNF-α (P = 0.456) when compared with the control
group, which suggests that the impairment of function was not mediated by an inflammatory response.

Knee Extensor Muscle Strength
In the downhill running group, strength of the knee extensors was reduced by 46.49 ±
6.55% immediately post-injury, and failed to significantly recover at 24 h or 48 h (p < 0.05).
This reduction is larger than what other studies have shown in quadriceps strength following a
bout of downhill running (Martin, Millet, Martin, Deley, & Lattier, 2004; Rowlands, Eston, &
Tilzey, 2001) which showed a 14 – 17% and 21 – 27% decline in force, respectively. The
larger force loss observed in this study is likely indicative of the longer duration of downhill
running, 1 h in the current study vs 15 min in Martin et al. 2004, and 30 min in Rowlands et al.
2001. Some of the force loss observed in the initial post injury measurement may be due to
fatigue from the metabolic disruption due to the downhill run. The persistent loss of force
observed in the injury group at 24 h and 48 h is confirmation that the subjects were significantly
injured by the downhill run. In support of this, previous studies have shown that downhill
running injures the knee extensor muscles (Byrnes et al., 1985; R. Eston, Lemmey, McHugh,
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Byrne, & Walsh, 2000; R. G. Eston, Mickleborough, & Baltzopoulos, 1995; Malm et al., 2004).
The absence of significant strength loss in the knee extensors for the control group (P > 0.05)
provides evidence that the strength assessment procedures did not significantly injure the KE
muscles.

Measurements of knee extensor muscle strength in the control group following a fatigue
protocol were 17.3 ± 9.8% lower than rested measures, but this change was not significant (P =
0.108). In the injury group, the fatigue protocol only led to a loss of 9.7 ± 4.9% which was also
not significant (P = 0.075). It was originally hypothesized that a bout of fatiguing contractions
would lead to a further reduction in strength, however, the 46.49 ± 6.55% reduction in strength
following the downhill run may have made it impractical to produce enough force with the knee
extensor muscles to achieve fatigue. Even when the resistance of the contraction was quite low
(55% of 53.5% of original strength) the subjects required considerable help to perform the 50
contractions.

Knee Extensor Twitch Strength
The knee extensors electrically stimulated strength measured prior to the fatiguing
protocol in the injury group was reduced by 49.66 ± 6.79% immediately post-injury, and 30.81 ±
14.24% 24 h post-injury. By 48 h post-injury the electrically stimulated force had recovered to
the point that there was no longer a significant difference between the control and injury group.
This would suggest that changes within the muscle account for most of the force loss
immediately after injury, but other factors may become more important throughout recovery.
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Twitch strength in the knee extensor muscles following the fatigue protocol was not
significantly affected. In the control group there was only an overall 1.3 ± 7.7% reduction, and
in the injury group there was only an overall reduction of twitch strength of 2.5 ± 6.7%
compared to rested measures. It appears that the fatigue protocol was not of sufficient intensity
to induce peripheral muscle fatigue within the knee extensor muscles.

Voluntary Activation of the Knee Extensor Muscles
This study found a significant interaction effect on knee extensor voluntary activation
prior to the fatiguing protocol (P = 0.047), but post-hoc analysis did not detect any significant
differences, suggesting that this study was underpowered for the voluntary activation measures
in the knee extensor muscles. This might make sense because subject number projection was
based on the effect size for the elbow flexor muscle MVC. Knee extensor MVC and voluntary
activation have been found to be reduced after a 30-km running race (Millet, Martin, Lattier, &
Ballay, 2003), and a 24 h treadmill run (Gimenez, Kerhervé, Messonnier, Féasson, & Millet,
2013). This failure to detect differences reflects the low power, which may be due to the large
amount of variation in knee extensor voluntary activation in this study. Two of the injury group
subjects experienced < 10% decline in activation at 24 and 48 h post injury, while the remaining
subjects had a mean decline in voluntary activation of 44% and 48% respectively over the same
period. Despite this weakness, when taken in context with the electrically evoked force of knee
extensors, it appears most of the force loss after injury may be attributed to changes in the
skeletal muscle.
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Measurements after the fatiguing protocol showed a significant 13.7 ± 4.9% change in
voluntary activation for the control group, without any significant changes in voluntary
activation over time (P = 0.986). In the injury group, there was an overall 13.2 ± 11.5% change
in measurements after the fatiguing protocol, but these changes were not significant (P = 0.285),
however, activation did change over time in the injury group (P = 0.003). While the fatigue
protocol was able to reduce voluntary activation in the control group, it appears the overall
decline in activation from the downhill run prevented the fatigue protocol from lowering
activation further in the injury group. The low amount of work performed following the injury
protocol, and the fact that the control group did not suffer this reduction make interpreting these
results difficult.

Strength of the Elbow Flexor Muscles
Elbow flexor MVC strength in the injury group was found to be significantly reduced in
the injury group after 1 h of downhill running, immediately post-injury, and 24 h post-injury, but
not in the control group. The magnitude of the decline was 13.2 ± 3.9% immediately post-injury,
and 17.3 ± 4.0% 24 h post-injury. At 48 h post injury, there was a 9.0 ± 3.3% change, but this
was no longer significant. These changes suggest that the downhill run led to a decline in elbow
flexor MVC strength.

The fatigue protocol significantly reduced strength by 27.4 ± 4.1% in the control group
and 23.7 ± 4.2% in the injury group. In both cases, there were no significant changes over time.
While the amount of strength lost due to the protocol seems relatively constant across time points
in both the control and injury groups, this result is difficult to interpret because subjects in the
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injury group required considerable help to complete the 50 contractions. If this study were
performed again, it would be interesting to record the subjects’ rating of perceived exertion
during the fatigue protocol to examine whether the perception of effort changes as a result of the
downhill run.

Currently, there do not appear to be any published studies demonstrating that exerciseinduced injury to the leg muscles alters MVC strength in the elbow flexors. Some evidence
suggests that fatiguing the legs produces a small (6.8%) reduction in strength of the elbow
flexors due to inhibitory signals from the group III/IV afferent nerves (Sidhu et al., 2014). This
is in contrast to findings from another study that showed no effect of single leg high intensity
cycling on the uninvolved limb (Elmer, Amann, McDaniel, Martin, & Martin, 2013). The mean
MVC strength loss in the elbow flexors at 24 h in this study was 2.5 times higher than that
previously observed in leg fatigue protocols (Sidhu et al., 2014).

Twitch Force of the Elbow Flexor Muscles
No significant changes occurred in twitch force of the elbow flexors when comparing the
control and injury groups over time (P > 0.187). This suggests that the elbow flexor muscles
were not significantly injured by the downhill run. The fatigue protocol led to an overall
reduction of 15.4 ± 9.4% in the control group, which was not significant. The injury group
experienced a significant 24.4 ± 7.2% reduction in twitch force of the elbow flexors.
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Elbow Flexor Voluntary Activation
Elbow flexor activation was found to be significantly reduced in the injury group at 24 h
(P = 0.030) and 48 h (P = 0.039) compared with controls. The magnitude of the reductions at 24
h (22.96 ± 9.096) are larger than the force reductions observed in the elbow flexors (17.7 ±
5.6%). Since there was no change in the electrically stimulated strength in the elbow flexors (P
> 0.05) at any time point, all the force loss observed can be attributed to changes in voluntary
activation. This suggests that the central nervous system’s ability to activate peripheral muscle
was reduced, but due to limitations in the study design, the exact site (brain or spinal cord) of the
dysfunction cannot be determined. It may be possible to examine specific sites of the CNS to
determine where the dysfunction occurs by testing the motor cortex silent period, and h-reflex
(Fuhr, Agostino, & Hallett, 1991; Triggs et al., 1993).

Measurements of elbow flexor activation taken after the fatiguing protocol showed no
differences in activation. This suggests that immediately after a set of fatiguing contractions the
deficit in elbow flexor strength are eliminated when peripheral fatigue is present. However, it is
also possible that the large variation present in the elbow flexor voluntary activation
measurements (see Figure 2.12) after the fatiguing contraction may have obscured any effect
present, making it difficult to identify whether peripheral muscle fatigue is altering voluntary
activation in the elbow flexors.

One previous study has shown that fatiguing the knee extensors led to a small decline in
force of the elbow flexors. An intrathecal injection of fentanyl prevented this loss of force from
the elbow flexor muscles suggesting the effect was due to the activation of group III/IV afferent
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nerves, but the changes observed in the current study exceed the 6.86% change observed
previously (Sidhu et al., 2014) suggesting other mechanisms may have played a role. Previous
evidence suggests that the pro-inflammatory cytokines retained within the muscle are capable of
sensitizing the group III/IV afferent nerves (Hoheisel, Unger, & Mense, 2005). Whether proinflammatory cytokines are present in the muscle after 1 h of downhill running would need to be
examined through muscle biopsies. One possible explanation for the greater force loss observed
in this study is that afferent nerve activation was much greater than previously observed due to
the sensitization by pro-inflammatory cytokines. To test for this, future studies should examine
force loss in the elbow flexors using a similar injury protocol to this study with the additional
application of intrathecal fentanyl to determine the role of afferent nerves in the force loss
observed.

Since there are significant differences between the control group elbow flexor muscle
activation and the injury group in activation, but not in twitch force, it follows that the force
losses observed were likely due to a decline in activation, not in peripheral changes within the
muscle. This excludes the possibility that significant injury or fatigue occurred at 24 h in the
elbow flexors due to the downhill run. This reduction in elbow flexor strength was mostly
recovered by 48 h post-injury based on the lack of significant differences in elbow strength
between the control and injury groups at the 48 h time point.

Pro-inflammatory Cytokines

Prior to conducting this experiment, it was hypothesized that 1 h of downhill running
would significantly elevate TNF-α and IL-1β. This study did not find any evidence that pro84

inflammatory cytokines were elevated after 1 h of downhill running. IL-1β levels remained
below the detectable limit (0.3 pg/ml) for most subjects. TNF-α was detected, but the
concentrations in blood declined post-injury, and remained reduced for at least 24 h post-injury
for both groups (see Figure 2.16). The measurements of pro-inflammatory cytokines should be
interpreted with caution since the overall number of usable samples obtained for testing was low
for IL-1β (n =9) and TNF-α (n = 5).

Measuring IL-1β has been a recurring challenge, as noted throughout the literature, with
some studies showing muscle injury increased IL-1β (Evans et al., 1986; Haahr et al., 1991;
Ostrowski, Rohde, Asp, & Pedersen, 1998; Pournot et al., 2011; Scott et al., 2013; Sprenger et
al., 1992), and other showing no change (Smith et al., 2007; Van de Vyver, 2013). The
physiological concentrations in blood are very low, femtomolar to picomolar concentration,
making its detection difficult (Moldoveanu, Shephard, & Shek, 2001). It is also possible that
something in the circulation interferes with the test measurement. The results from TNF-α
testing are more interpretable. While changes were observed in TNF-α over time, these changes
occurred uniformly across groups. This likely means that TNF-α in the blood played no role in
the communication of the injury of the knee extensors to the central nervous system, as
previously described. However, the manufacturer of the ELISA kits used in this study reported
that soluble inhibitors or anything bound to the cytokines would likely interfere with the test. It
is also possible that elevations of the cytokines in question occur outside the measurement time
points of this experiment.
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The decline in TNF-α across both groups in the post measurements (see Fig 2.16)
suggests that the exercise associated with the fatiguing protocol and the interpolated twitch
procedure led to a decrease in measurable plasma TNF-α. This decrease could have occurred
either due to increased metabolism of the cytokine, the uptake TNF-α by some other tissue, or
increased secretion of endogenous soluble TNF inhibitors. Moderate exercise has been shown to
increase glomerular filtration in the kidneys leading to increased urinary protein after exercise
(Bellinghieri, Savica, & Santoro, 2008; Poortmans, 1985). Previous research suggests that
exercise increases the urinary excretion of lipoxin A 4, another cytokine (Gangemi et al., 2003).
If funding becomes available, the urine samples should be used to confirm whether urinary
excretion of TNF-α or IL-1β was elevated after exercise.

Role of the Central Nervous System in MVC Strength Loss after Muscle Injury
This study demonstrated that a 1 h downhill run at 75% VO2max can reduce both knee
extensor and elbow flexor strength for up to 48 hours. Strength loss in the knee extensors results
primarily from the injury associated with eccentric contractions as described by previous
reviewers (R. G. Eston et al., 1995). Without an external load being applied to the elbow flexors,
it is unlikely that injury occurred in these muscles. In support of this, no changes were found in
elbow flexor electrically stimulated strength. Changes in strength were observed in the
immediate post measurements for both control and injury groups that suggest immediate changes
may be due to fatigue from the testing procedures. The time frame associated with these
measurements was approximately 5 h, and may have contributed to a loss in strength. However,
significant reductions in MVC strength were also observed at 24 h post injury, after MVC
strength reductions were resolved in the control group. Some mechanism(s) likely exist to
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transmit the information of muscle injury from the injured muscle to the central nervous system
to achieve this effect. Based on the evidence obtained in this study, that mechanism is likely not
circulating pro-inflammatory cytokines.

CNS Dysfunction Possibly Due to the Perception of Pain
This study found that downhill running compared with control significantly elevated pain
in the knee extensors (P < 0.05). In the injury group, there was a change in the elbow flexors of
47.2 ± 15.0 mm immediately post-injury, 45.6 ± 12.7 mm 24 h post-injury, and 30.5 ± 9.5 mm
48 h post-injury but this change was not significant (p > 0.05). It is possible that this
measurement was under powered due to a small sample size (n = 10). It is unclear why there
would be any change in pain in the elbow flexor muscles since the twitch force measurements
suggest there was no injury present in the elbow flexor muscles. The timing of the pain is
uncharacteristic of an exercise induce muscle injury, which typically results in significant
widespread pain 24 h following the injury (Cheung, Hume, & Maxwell, 2003). Instead, there is
an immediate 87.8 ± 9.3 mm increase in pain following the downhill run that failed to increase
further at 24 h post-injury.

Previous studies suggest that experimentally inducing pain can have varied effects at
submaximal intensities, with some studies showing increased muscle activity (Del Santo, Gelli,
Spidalieri, & Rossi, 2007; Svensson, Houe, & Arendt-Nielsen, 1997), others showing decreased
muscle activity (Del Santo et al., 2007; Farina, Arendt-Nielsen, & Graven-Nielsen, 2005) or no
change (Farina, Arendt-Nielsen, Merletti, & Graven-Nielsen, 2004). The differences in these
studies may be due to the intensity at which force is measured. Maximal force and voluntary
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activation have been shown to be reduced by experimentally induced pain (Graven-Nielsen,
Svensson, & Arendt-Nielsen, 1997; Graven‐Nielsen, Lund, Arendt‐Nielsen, Danneskiold‐
Samsøe, & Bliddal, 2002). This suggests that some of the force loss may be attributed to pain,
but pain would have to be experimental manipulated to confirm this possibility.

CNS Dysfunction and the Inflammatory Response
First, the inflammatory particles TNF-α and brain derived neurotrophic factor, retained
within the injured muscles have been shown to sensitize group IV afferent nerves making them
discharge at lower force thresholds (Hoheisel et al., 2005). If the group IV afferents were
affected in this manner, it would likely reduce maximal force production, since the spinal cord
would likely reduce motor unit recruitment once they are activated (Amann, 2011; Amann &
Dempsey, 2008; Amann et al., 2008). Future studies should take muscle biopsies to determine
whether pro-inflammatory cytokines from the injured muscle can cross into uninjured muscles,
since an attenuation of inflammatory pathways has been noted in response to eccentric exercise
in both the injured and uninjured muscles (Hubal, Chen, Thompson, & Clarkson, 2008).

Second, the pro-inflammatory cytokines secreted by the injured muscle could cross the
blood brain barrier as demonstrated in other studies (Carmichael et al., 2010; Gabay, Lamacchia,
& Palmer, 2010; Lee, Liu, Dickson, Brosnan, & Berman, 1993) and alter the function of the
substantia nigra (Brydon, Harrison, Walker, Steptoe, & Critchley, 2008; Ferrari et al., 2006;
Herrera, Tomas-Camardiel, Venero, Cano, & Machado, 2005), which leads to a reduced ability
to initiate/activate muscle for a physical task (Brydon et al., 2008; Godoy, Tarelli, Ferrari,
Sarchi, & Pitossi, 2008). The results from this study do not support a role for circulating IL-1β
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and TNF-α following 1 h of downhill running. The search may need to broadened in the future
to include other circulating proteins since other circulating proteins could contribute to brain
dysfunction as recently demonstrated in models of Parkinson’s disease (Mulak & Bonaz, 2015).

Practical Application of Findings
The demonstration that muscle injury can affect neuromuscular function of an uninjured
muscle group suggesting that the central nervous system senses the injury through some
signaling mechanism and reduces force generation of skeletal muscle by lowering activation.
Other muscle groups would need to be tested to determine whether this effect is global, or
particular to the knee extensors and elbow flexors. It must be understood that the injury model
used may determine whether such a widespread effect would occur.

The benefits to this mechanism are three-fold. First, from an evolutionary perspective,
activity following a muscle injury would be significantly lower reducing exposure to possible
predators during the recovery period. Second, the reduction in overall activity preserves energy
that can be used to recover from the injury. Third, having an overall reduction instead of
targeted reduction in voluntary activation would simplify the circuitry in the brain, lowering the
energy needed to interpret signals of peripheral energy.

From a functional standpoint, the loss of strength in the uninjured muscle should be taken
into account on days following muscle injury, and may affect joint stability, as previous studies
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have shown that loss of force due to fatigue can impair joint stability (Gribble, Hertel, Denegar,
& Buckley, 2004; Johnston 3rd, Howard, Cawley, & Losse, 1998; Yaggie & McGregor, 2002).
This decreased joint stability may increase the probability of injury, and it may be necessary to
develop recommendations for exercise that limit high risk activities in the uninjured muscles
following an injury to another muscle group. In the present study, 1 h of downhill running in
untrained subjects was sufficient to reduce force in the uninvolved elbow flexor muscles.

It is possible that more severe injury models, such as occur from surgical procedures
could also produce widespread neuromuscular dysfunction, which is seen in ICU acquired
weakness (Haas & Herridge, 2015; Na & Koh, 2011) where suppressed neuromuscular function
can lead to life-threatening conditions. From a methodological standpoint, researchers should be
aware that injury may affect neuromuscular function at locations distant from the injury, and not
assume that a given injury model only affects the targeted muscles.

Conclusion

In summary, 1 h of downhill running was sufficient to induce injury in the knee
extensors, reducing strength for up to 48 h. The injury of the leg muscles resulted in reduced
strength and activation of the elbow flexors 24 h after the downhill run. This demonstrates that
muscle injury can affect strength in other muscles distant from the site of injury by impairing
voluntary activation of the uninjured muscle. The mechanism behind this reduced voluntary
activation remains undetermined.
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APPENDIX B: INSTITUIONAL REVIEW BOARD LETTER OF APPROVAL
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APPENDIX C: INSTITUTIONAL REVIEW BOARD AMENDMENT ONE LETTER OF
APPROVAL
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APPENDIX D: INSTITUTIONAL REVIEW BOARD AMENDMENT TWO LETTER OF
APPROVAL
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APPENDIX E: INSTITUTIONAL REVIEW BOARD AMENDMENT THREE LETTER OF
APPROVAL
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APPENDIX F: SUBJECT RECRUITMENT FLYER

Have you ever wondered whether inflammation can cause muscle fatigue?
Researchers at Georgia State University, department of Kinesiology are
attempting to answer this question and would like you to volunteer! Participation
in this study involves having your strength tested, and running downhill on a
treadmill. The study may cause moderate to severe muscle soreness and other
injuries associated with running downhill. This study will require 7 hours of your
time over 5 separate days. During those 5 days, we will ask you not to do any
exercise other than the exercise for the research. You must also have properly
fitting running shoes.
Reasons to Volunteer:
• You are a University Student between the ages of 18-44.
• Get first-hand experience in research as a subject.
• Learn about the field of exercise physiology.

Signup today by contacting Kyle Brandenberger Today!
Kbrandenberger1@gsu.edu , The Sport Arena G01.
116

APPENDIX G: CONTROL GROUP INFORMED CONSENT FORM
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APPENDIX H: DOWNHILL RUNNING GROUP INFORMED CONSENT FORM
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APPENDIX I: HEALTH HISTORY QUESTIONNAIRE
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APPENDIX J: TREADMILL VO2MAX PROTOCOL

128

APPENDIX K: DATA COLLECTION FORM

Subject ID ______________

Trial__________________

Thigh Circumference

Upper Arm Circumference

Knee Extensor Force Curve
100 mA 120 mA 140 mA 160 mA 180 mA 200 mA 220 mA 240 mA 260 mA 280 mA 300 mA 320 mA 340 mA 360 mA 380 mA 400 mA 420 mA 440 mA 460 mA 480 mA 500 mA

Resting Knee Extensor: Peak Torque Prior to Twitch

Resting Knee Extensor: Activation

Fatiguing Knee Extensor: Peak Torque Prior to Twitch

Fatiguing Knee Extensor: Activation

Elbow Flexor Force Curve
60 mA

80 mA

100 mA 120 mA 140 mA 160 mA 180 mA 200 mA 220 mA 240 mA 260 mA 280 mA 300 mA 320 mA 340 mA 360 mA 380 mA 400 mA 420 mA 440 mA 460 mA

Resting Elbow Flexors: Peak Torque Prior to Twitch

Resting Elbow Flexors: Activation

Fatiguing Elbow Flexors: Peak Torque Prior to Twitch

Fatiguing Elbow Flexors: Activation
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APPENDIX L: MUSCLE SORENESS SCALE

Rating of Exercise Induced – Muscle Soreness
Visual Analogue Scale: 100 mm
Subject #
Date
Time
Trial/Step # (1-4)
Soreness Score (mm)

0

100

No Soreness

Very, Very Sore
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APPENDIX M: TREADMILL SPEED VALIDATION
Displayed Speed
(mph)
5
6
7
8
9
10
11

Mean Measured Speed
(mph)
5.041699
5.8024802
6.8587684
7.7832249
8.630705
10.2839551
11.8254628

Speeds were measured in duplicate using a standard stopwatch. The mean of these two
measurements is shown above.
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APPENDIX N: KNEE EXTENSOR STRENGTH DATA
KNEE EXTENSOR STRENGTH AT REST FOR EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
0.00

Immediate
Post-Injury
0.95
1.44
0.53
1.07
0.94
0.80
0.70
0.34
0.48
0.24
0.52
0.51
0.71
0.34

24 h PostInjury
1.08
1.30
0.80
0.98
0.88
1.13
0.38
0.33
0.60
0.57
0.78
0.58
0.78
0.30

48 h Post
Injury
1.05
1.39
0.78
1.02
0.84
1.14
0.30
0.43
0.70
0.56
0.77
0.57
0.80
0.32

KNEE EXTENSOR STRENGTH AFTER A FATIGUING PROTOCOL FOR EACH
MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury

Immediate
Post-Injury

24 h PostInjury

48 h Post
Injury

0.82
0.92
0.90
0.66
0.96
0.49
0.80
0.72
0.95
0.83
0.74
0.92

0.89
1.17
0.55
0.77
0.85
0.73
0.66
0.34
0.35
0.25
0.68
0.43

0.94
1.12
0.61
0.65
0.82
0.75
0.42
0.27
0.49
0.35
0.49
0.42

0.85
1.28
0.49
0.89
0.98
0.87
0.37
0.37
0.58
0.49
0.72
0.38

0.81
0.14

0.64
0.27

0.61
0.26

0.69
0.29
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APPENDIX O: KNEE EXTENSOR VOLUNTARY ACTIVATION DATA
KNEE EXTENSOR VOLUNTARY ACTIVATION AT REST FOR EACH MEASURED TIME
POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury

Immediate
Post-Injury

24 h PostInjury

48 h Post
Injury

79.92
47.58
84.07
67.19
67.30
88.83
86.84
97.89
68.17
56.72
95.13

77.15
84.39
71.66
71.44
59.08
70.35
38.48
75.53
50.12
39.61
83.78

73.90
51.72
69.33
74.22
63.90
96.45
23.78
50.24
55.25
53.17
93.27

83.82
59.03
55.56
88.16
69.07
87.84
37.89
58.77
56.53
38.47
90.36

76.33
16.13

65.60
16.44

64.11
20.72

65.95
19.33

KNEE EXTENSOR VOLUNTARY ACTIVATION AFTER A FATIGUING PROTOCOL FOR
EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury

Immediate
Post-Injury

24 h PostInjury

48 h Post
Injury

65.87
51.97
82.27
40.32
54.69
52.02
55.11
98.60
57.80
38.05
77.63
42.10

70.81
70.67
47.89
44.31
48.69
64.80
38.99
62.28
35.11
39.09
77.39
45.00

79.78
48.33
58.24
48.23
57.15
67.88
12.91
33.84
39.83
29.69
67.80
25.36

69.50
48.10
36.31
69.60
61.51
72.53
16.22
44.99
45.24
39.04
75.94
26.07

59.70
18.35

53.75
14.58

47.42
19.84

50.42
19.42

133

APPENDIX P: KNEE EXTENSOR ELECTICALLY STIMULATED STRENGTH DATA
KNEE EXTENSOR ELECTRICALLY STIMULATED STRENGTH AT EACH MEASURED
TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury

Immediate
Post-Injury

24 h PostInjury

48 h Post
Injury

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

0.50
0.95
0.61
0.99
0.96
1.02
0.54
0.50
0.59
0.41
0.47

0.68
1.02
0.92
0.97
0.89
1.07
0.56
0.68
0.87
0.80
0.55

0.70
0.96
0.87
0.93
0.90
1.05
0.47
0.70
0.99
0.79
0.68

1.00
0.00

0.69
0.24

0.82
0.18

0.82
0.17

KNEE EXTENSOR ELECTRICALLY STIMULATED STRENGTH AT EACH MEASURED
TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury

Immediate
Post-Injury

24 h PostInjury

48 h Post
Injury

0.73
1.16
0.97
0.97
1.04
0.98
0.66
0.73
1.06
0.99
1.11

0.54
0.92
0.82
0.97
0.98
0.97
0.61
0.54
0.65
0.44
0.48

0.64
1.10
0.95
0.95
0.93
1.07
0.74
0.64
0.90
0.73
0.46

0.71
1.09
0.79
0.96
1.01
1.07
0.29
0.71
0.98
0.81
0.60

0.95
0.17

0.72
0.22

0.83
0.20

0.82
0.24
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APPENDIX Q: ELBOW FLEXOR STRENGTH DATA
ELBOW FLEXOR STRENGTH AT REST FOR EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
0.00

Immediate
Post-Injury
0.86
0.92
1.10
0.88
0.93
0.90
0.87
1.00
0.92
0.71
0.93
0.79
0.90
0.10

24 h PostInjury
1.00
0.97
1.16
0.99
0.99
0.92
0.86
0.70
0.95
0.71
0.95
0.79
0.92
0.13

48 h Post
Injury
0.99
1.00
1.03
1.01
1.03
0.96
0.89
0.92
1.10
0.87
0.91
0.77
0.96
0.09

ELBOW FLEXOR STRENGTH AFTER A FATIGUING PROTOCOL FOR EACH
MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
0.50
0.93
0.81
0.66
0.65
0.65
0.78
0.67
0.89
0.46
0.56
0.70
0.69
0.15

Immediate
Post-Injury
0.41
0.74
0.81
0.75
0.81
0.73
0.81
0.62
0.69
0.53
0.52
0.67
0.67
0.13
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24 h PostInjury
0.64
0.76
0.85
0.64
0.73
0.69
0.86
0.66
0.60
0.64
0.74
0.62
0.70
0.09

48 h Post
Injury
0.68
0.72
0.78
0.74
0.65
0.71
0.81
0.65
0.40
0.67
0.77
0.64
0.68
0.11

APPENDIX R: ELBOW FLEXOR ACTIVATION DATA
ELBOW FLEXOR VOLUNTARY ACTIVATION AT REST FOR EACH MEASURED TIME
POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
96.42
96.51
94.93
87.81
94.38
100.00
81.63
93.48
89.26
98.22
99.01
100.00
94.30
5.57

Immediate
Post-Injury
95.34
75.64
99.54
81.10
93.62
100.00
64.17
96.05
77.30
60.38
95.65
70.85
84.14
14.29

24 h PostInjury
97.54
91.27
96.62
96.08
94.65
97.60
52.27
90.29
93.30
51.91
94.73
53.52
84.15
19.18

48 h Post
Injury
92.99
98.45
91.90
95.49
86.95
99.44
69.62
82.00
97.56
73.75
94.80
66.57
87.46
11.71

ELBOW FLEXOR VOLUNTARY ACTIVATION AFTER A FATIGUING PROTOCOL FOR
EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
94.95
88.05
95.25
74.00
72.03
79.69
74.17
74.24
88.33
10.69
88.22
65.85
75.46
22.52

Immediate
Post-Injury
92.52
73.27
87.88
93.60
87.85
88.76
77.54
74.53
69.13
57.46
64.85
70.16
78.13
11.81
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24 h PostInjury
94.78
65.19
90.15
80.17
82.61
85.38
68.12
87.72
82.92
13.89
96.32
76.13
76.95
22.00

48 h Post
Injury
84.37
70.41
91.65
81.69
60.74
79.29
64.26
64.22
88.42
34.02
77.39
51.05
70.63
16.77

APPENDIX S: ELBOW FLEXOR ELECTICALLY STIMULATED STRENGTH DATA
ELBOW FLEXOR ELECTRICALLY STIMULATED STRENGTH AT REST FOR EACH
MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury

Immediate
Post-Injury

24 h PostInjury

48 h Post
Injury

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

1.00
0.93
0.74
0.67
0.48
1.19
0.96
1.00
0.97
1.26
0.81
0.88

1.57
0.85
0.96
0.71
1.15
1.21
0.96
1.57
0.93
0.71
0.97
0.96

1.15
1.15
0.71
0.86
0.58
0.99
0.77
1.15
0.91
1.12
0.90
0.97

1.00
0.00

0.91
0.22

1.05
0.28

0.94
0.19

ELBOW FLEXOR ELECTRICALLY STIMULATED STRENGTH AFTER A FATIGUING
PROTOCOL FOR EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury

Immediate
Post-Injury

24 h PostInjury

48 h Post
Injury

0.60
1.04
0.47
0.83
0.76
0.73
0.91
0.60
0.66
0.52
0.53
0.75

0.65
0.98
0.77
0.56
0.31
1.19
1.10
0.65
0.65
1.00
0.37
0.78

1.22
0.95
0.72
0.61
1.08
1.06
0.83
1.22
0.78
0.50
0.52
0.82

0.98
1.10
0.55
0.88
0.35
0.78
0.78
0.98
0.75
0.76
0.59
0.90

0.70
0.17

0.75
0.27

0.86
0.25

0.78
0.21
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APPENDIX T: SERUM IL-1Β DATA
SERUM IL-1β AT EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
-

Immediate
Post-Injury
-

24 h PostInjury
-

48 h Post
Injury
-

0.00
0.00
0.00
0.00

0.00
0.07
0.00
0.00

0.00
0.00
0.00
0.00

0.00
0.00
0.00
0.00

-

-

-

-

0.56
0.00
0.00
0.00
0.00

0.48
0.01
0.00
0.00
0.18

0.36
0.00
0.00
0.00
0.00

0.21
0.00
0.00
0.52
0.00

0.06
0.19

0.08
0.16

0.04
0.12

0.08
0.18
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APPENDIX U: SERUM TNF-Α DATA
SERUM TNF-α AT EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
-

Immediate
Post-Injury
-

24 h PostInjury
-

48 h Post
Injury
-

3.64
3.79
3.08
3.70

1.81

3.11
1.47
2.60
2.00

2.23
1.93
0.96
0.90

1.77

-

-

-

-

5.28
3.21
3.57
3.75
3.57

2.49

3.46
1.97
1.97
1.89
1.42

3.27
1.16
1.71
4.81
1.52

2.21
0.70

2.06
1.27

3.73
0.63

1.36
1.26

1.73
0.48
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APPENDIX V: UPPER ARM PAIN DATA
UPPER ARM PAIN AT EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
-

Immediate
Post-Injury
-

24 h PostInjury
-

48 h Post
Injury
-

0.00
0.00
0.00
0.00
0.00
0.00

11.50
63.00
3.00
5.50
19.00
97.00

65.50
6.00
6.00
6.50
3.00
85.50

44.50
5.00
2.00
0.00
11.00
15.00

-

-

-

-

13.00
0.00
7.00
2.00

16.00
36.00
97.00
12.00

31.50
64.00
52.00
17.00

41.00
49.50
66.00
3.00

2.20
4.39

36.00
36.60

33.70
30.64

23.70
24.12
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APPENDIX W: THIGH PAIN DATA
THIGH PAIN AT EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
-

Immediate
Post-Injury
-

24 h PostInjury
-

48 h Post
Injury
-

0.00
0.00
1.00
0.00
1.00
0.00

0.00
58.00
9.00
5.50
42.00
98.00

23.00
2.00
5.00
8.50
3.00
82.50

7.50
12.00
2.00
0.00
12.00
64.00

-

-

-

-

12.50
1.00
3.00
1.00

88.00
100.00
71.50
99.00

90.50
100.00
79.50
65.00

80.00
100.00
85.50
82.00

1.95
3.82

57.10
40.68

45.90
40.98

44.50
40.93
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APPENDIX X: UPPER ARM CIRCUMFERENCE DATA
UPPER ARM CIRCUMFERENCE AT EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
-

Immediate
Post-Injury
-

24 h PostInjury
-

48 h Post
Injury
-

22.83
28.53
31.00
28.17
28.73
29.40

22.80
28.20
31.87
29.17
28.90
29.80

23.27
28.50
30.97
28.53
29.27
29.97

23.23
28.33
31.77
29.53
28.83
30.03

-

-

-

-

31.40
28.20
32.50
24.43

30.20
28.40
32.50
24.23

30.50
29.20
32.23
24.40

30.70
28.73
32.23
24.83

28.52
2.99

28.61
3.04

28.68
2.81

28.82
2.85
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APPENDIX Y: THIGH CIRCUMFERENCE DATA
THIGH CIRCUMFERENCE AT EACH MEASURED TIME POINT

Subject
1
2
3
4
5
6
7
8
9
10
11
12
Mean
SD

Immediate PreInjury
-

Immediate
Post-Injury
-

24 h PostInjury
-

48 h Post
Injury
-

49.97
49.90
53.13
47.90
48.97
56.37

49.63
50.20
53.77
47.20
48.30
56.70

48.77
51.20
52.97
47.03
51.07
56.50

48.33
50.87
53.27
48.97
48.13
54.00

-

-

-

-

59.57
52.37
52.17
51.50

57.73
49.70
52.07
48.53

56.57
54.23
53.20
50.93

56.17
52.67
55.20
50.60

52.19
3.53

51.38
3.61

52.25
3.09

51.82
2.87
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